Chemistry and mineralogy

/wiki/Xenon
Xenon
This article is about the chemical element.  For other uses, see Xenon (disambiguation) . Xenon, 54 Xe A xenon-filled discharge tube glowing light blue Spectral lines of xenon General properties Name, symbol xenon, Xe Appearance colorless gas, exhibiting a blue glow when placed in a high voltage electric field Pronunciation / ˈ z ɛ n ɒ n / [ 1 ] or / ˈ z iː n ɒ n / [ 2 ] ZEN -on or ZEE -non Xenon in the periodic table Kr ↑ Xe ↓ Rn iodine ← xenon → caesium Atomic number ( Z ) 54 Group , block group 18 (noble gases) , p-block Period period 5 Element category noble gas Standard atomic weight (±) ( A r ) 131.293(6) [ 3 ] Electron configuration [ Kr ] 4d 10 5s 2 5p 6 per shell 2, 8, 18, 18, 8 Physical properties Phase gas Melting point 161.40 K ​(−111.75 °C, ​−169.15 °F) Boiling point 165.051 K ​(−108.099 °C, ​−162.578 °F) Density at stp (0 °C and 101.325 kPa ) 5.894 g/L when liquid, at b.p. 2.942 g/cm 3 [ 4 ] Triple point 161.405 K, ​81.77 kPa [ 5 ] Critical point 289.733 K, 5.842 MPa [ 5 ] Heat of fusion 2.27 kJ/mol Heat of vaporization 12.64 kJ/mol Molar heat capacity 21.01 [ 6 ] J/(mol·K) vapor pressure P (Pa) 1 10 100 1 k 10 k 100 k at T (K) 83 92 103 117 137 165 Atomic properties Oxidation states 0 , +1, +2, +4, +6, +8 ​(rarely more than 0; a weakly acidic oxide) Electronegativity Pauling scale: 2.6 Ionization energies 1st: 1170.4 kJ/mol 2nd: 2046.4 kJ/mol 3rd: 3099.4 kJ/mol Covalent radius 140±9 pm Van der Waals radius 216 pm Miscellanea Crystal structure ​ face-centered cubic (fcc) Speed of sound gas: 169 m·s −1 liquid: 1090 m/s Thermal conductivity 5.65×10 −3 W/(m·K) Magnetic ordering diamagnetic [ 7 ] CAS Number 7440-63-3 History Discovery and first isolation William Ramsay and Morris Travers (1898) Most stable isotopes of xenon iso NA half-life DM DE ( MeV ) DP 124 Xe 0.095% >4.8×10 16 y ( β + β + ) 0.825 124 Te 125 Xe syn 16.9 h ε 1.652 125 I 126 Xe 0.089% – (β + β + ) 0.8973 126 Te 127 Xe syn 36.345 d ε 0.662 127 I 128 Xe 1.91% – ( SF ) <35.047 129 Xe 26.4% – (SF) <33.947 130 Xe 4.07% – (SF) <32.483 131 Xe 21.2% – (SF) <31.140 132 Xe 26.9% – (SF) <30.885 133 Xe syn 5.247 d β − 0.427 133 Cs 134 Xe 10.4% >1.1×10 16 y ( β − β − ) 0.819 134 Ba 135 Xe syn 9.14 h β − 1.16 135 Cs 136 Xe 8.86% 2.165×10 21 y [ 8 ] β − β − 2.45783 [ 9 ] 136 Ba Decay modes in parentheses are predicted, but have not yet been observed view talk edit · references Xenon is a chemical element with symbol Xe and atomic number 54. It is a colorless, dense, odorless noble gas , that occurs in the Earth's atmosphere in trace amounts. [ 10 ] Although generally unreactive, xenon can undergo a few chemical reactions such as the formation of xenon hexafluoroplatinate , the first noble gas compound to be synthesized. [ 11 ] [ 12 ] [ 13 ] Naturally occurring xenon consists of eight stable isotopes . There are also over 40 unstable isotopes that undergo radioactive decay . The isotope ratios of xenon are an important tool for studying the early history of the Solar System . [ 14 ] Radioactive xenon-135 is produced by beta decay from iodine-135 (which is a product of nuclear fission ), and it acts as the most significant neutron absorber in nuclear reactors . [ 15 ] Xenon is used in flash lamps [ 16 ] and arc lamps , [ 17 ] and as a general anesthetic . [ 18 ] The first excimer laser design used a xenon dimer molecule (Xe 2 ) as its lasing medium , [ 19 ] and the earliest laser designs used xenon flash lamps as pumps . [ 20 ] Xenon is also being used to search for hypothetical weakly interacting massive particles [ 21 ] and as the propellant for ion thrusters in spacecraft . [ 22 ] Contents 1 History 2 Characteristics 3 Occurrence and production 4 Isotopes and isotopic studies 5 Compounds 5.1 Halides 5.2 Oxides and oxohalides 5.3 Other compounds 5.4 Clathrates and excimers 6 Applications 6.1 Illumination and optics 6.1.1 Gas-discharge lamps 6.1.2 Lasers 6.2 Medical 6.2.1 Anesthesia 6.2.2 Neuroprotectant 6.2.3 Doping 6.2.4 Imaging 6.3 NMR spectroscopy 6.4 Other 7 Precautions 8 See also 9 References 10 External links History [ edit ] Xenon was discovered in England by the Scottish chemist William Ramsay and English chemist Morris Travers in September 1898, [ 23 ] shortly after their discovery of the elements krypton and neon . They found xenon in the residue left over from evaporating components of liquid air . [ 24 ] [ 25 ] Ramsay suggested the name xenon for this gas from the Greek word ξένον [xenon], neuter singular form of ξένος [xenos], meaning 'foreign(er)', 'strange(r)', or 'guest'. [ 26 ] [ 27 ] In 1902, Ramsay estimated the proportion of xenon in the Earth's atmosphere as one part in 20 million. [ 28 ] During the 1930s, American engineer Harold Edgerton began exploring strobe light technology for high speed photography . This led him to the invention of the xenon flash lamp , in which light is generated by sending a brief electric current through a tube filled with xenon gas. In 1934, Edgerton was able to generate flashes as brief as one microsecond with this method. [ 16 ] [ 29 ] [ 30 ] In 1939, American physician Albert R. Behnke Jr. began exploring the causes of "drunkenness" in deep-sea divers. He tested the effects of varying the breathing mixtures on his subjects, and discovered that this caused the divers to perceive a change in depth. From his results, he deduced that xenon gas could serve as an anesthetic . Although Russian toxicologist Nikolay V. Lazarev apparently studied xenon anesthesia in 1941, the first published report confirming xenon anesthesia was in 1946 by American medical researcher John H. Lawrence, who experimented on mice. Xenon was first used as a surgical anesthetic in 1951 by American anesthesiologist Stuart C. Cullen, who successfully operated on two patients. [ 31 ] An acrylic cube specially prepared for element collectors containing liquefied xenon Xenon and the other noble gases were for a long time considered to be completely chemically inert and not able to form compounds . However, while teaching at the University of British Columbia , Neil Bartlett discovered that the gas platinum hexafluoride (PtF 6 ) was a powerful oxidizing agent that could oxidize oxygen gas (O 2 ) to form dioxygenyl hexafluoroplatinate (O 2 + [PtF 6 ] − ). [ 32 ] Since O 2 and xenon have almost the same first ionization potential , Bartlett realized that platinum hexafluoride might also be able to oxidize xenon. On March 23, 1962, he mixed the two gases and produced the first known compound of a noble gas, xenon hexafluoroplatinate . [ 33 ] [ 13 ] Bartlett thought its composition to be Xe + [PtF 6 ] − , although later work has revealed that it was probably a mixture of various xenon-containing salts. [ 34 ] [ 35 ] [ 36 ] Since then, many other xenon compounds have been discovered, [ 37 ] along with some compounds of the noble gases argon , krypton , and radon , including argon fluorohydride (HArF), [ 38 ] krypton difluoride (KrF 2 ), [ 39 ] [ 40 ] and radon fluoride . [ 41 ] By 1971, more than 80 xenon compounds were known. [ 42 ] [ 43 ] In November 1999 IBM scientists demonstrated a technology capable of manipulating individual atoms . The program, called IBM in atoms , used a scanning tunneling microscope to arrange 35 individual xenon atoms on a substrate of chilled crystal of nickel to spell out the three letter company acronym. It was the first time atoms had been precisely positioned on a flat surface. [ 44 ] Characteristics [ edit ] Liquid (featureless) and crystalline solid Xe nanoparticles produced by implanting Xe + ions into aluminium at room temperature. Xenon has atomic number 54; that is, its nucleus contains 54 protons . At standard temperature and pressure , pure xenon gas has a density of 5.761 kg/m 3 , about 4.5 times the surface density of the Earth's atmosphere, 1.217 kg/m 3 . [ 45 ] As a liquid, xenon has a density of up to 3.100 g/mL, with the density maximum occurring at the triple point. [ 46 ] Notably, liquid xenon has a high polarizability due to its large atomic volume, and thus is an excellent solvent. It can dissolve hydrocarbons, biological molecules, and even water. [ 47 ] Under the same conditions, the density of solid xenon, 3.640 g/cm 3 , is higher than the average density of granite , 2.75 g/cm 3 . [ 46 ] Using gigapascals of pressure , xenon has been forced into a metallic phase. [ 48 ] Solid xenon changes from face-centered cubic (fcc) to hexagonal close packed (hcp) crystal phase under pressure and begins to turn metallic at about 140 GPa, with no noticeable volume change in the hcp phase. It is completely metallic at 155 GPa. When metallized, xenon looks sky blue because it absorbs red light and transmits other visible frequencies. Such behavior is unusual for a metal and is explained by the relatively small widths of the electron bands in metallic xenon. [ 49 ] [ 50 ] Xenon flash ( animated version ) Liquid or solid xenon nanoparticles can be formed at room temperature by implanting Xe + ions into a solid matrix. Many solids have lattice constants smaller than solid Xe. This results in compression of the implanted Xe to pressures that may be sufficient for its liquefaction or solidification. [ 51 ] Xenon is a member of the zero- valence elements that are called noble or inert gases . It is inert to most common chemical reactions (such as combustion, for example) because the outer valence shell contains eight electrons. This produces a stable, minimum energy configuration in which the outer electrons are tightly bound. [ 52 ] In a gas-filled tube , xenon emits a blue or lavenderish glow when the gas is excited by electrical discharge . Xenon emits a band of emission lines that span the visual spectrum, [ 53 ] but the most intense lines occur in the region of blue light, which produces the coloration. [ 54 ] Occurrence and production [ edit ] Xenon is a trace gas in Earth's atmosphere , occurring at 87±1 parts per billion (nL/L), or approximately 1 part per 11.5 million, [ 55 ] and is also found as a component in gases emitted from some mineral springs . Xenon is obtained commercially as a by-product of the separation of air into oxygen and nitrogen . After this separation, generally performed by fractional distillation in a double-column plant, the liquid oxygen produced will contain small quantities of krypton and xenon. By additional fractional distillation steps, the liquid oxygen may be enriched to contain 0.1–0.2% of a krypton/xenon mixture, which is extracted either via absorption onto silica gel or by distillation. Finally, the krypton/xenon mixture may be separated into krypton and xenon via distillation. [ 56 ] [ 57 ] Worldwide production of xenon in 1998 was estimated at 5,000–7,000 m 3 . [ 58 ] Because of its low abundance, xenon is much more expensive than the lighter noble gases—approximate prices for the purchase of small quantities in Europe in 1999 were 10 € /L for xenon, 1 €/L for krypton, and 0.20 €/L for neon; [ 58 ] the much more plentiful argon costs less than a cent per liter. Within the Solar System, the nucleon fraction of xenon is 1.56 × 10 −8 , for an abundance of approximately one part in 630 thousand of the total mass. [ 59 ] Xenon is relatively rare in the Sun 's atmosphere, on Earth , and in asteroids and comets . The planet Jupiter has an unusually high abundance of xenon in its atmosphere; about 2.6 times as much as the Sun. [ 60 ] [ 61 ] This high abundance remains unexplained and may have been caused by an early and rapid buildup of planetesimals —small, subplanetary bodies—before the presolar disk began to heat up. [ 62 ] (Otherwise, xenon would not have been trapped in the planetesimal ices.) The problem of the low terrestrial xenon may potentially be explained by covalent bonding of xenon to oxygen within quartz , hence reducing the outgassing of xenon into the atmosphere. [ 63 ] Unlike the lower mass noble gases, the normal stellar nucleosynthesis process inside a star does not form xenon. Elements more massive than iron-56 have a net energy cost to produce through fusion, so there is no energy gain for a star when creating xenon. [ 64 ] Instead, xenon is formed during supernova explosions, [ 65 ] by the slow neutron capture process ( s-process ) of red giant stars that have exhausted the hydrogen at their cores and entered the asymptotic giant branch , [ 66 ] in classical nova explosions [ 67 ] and from the radioactive decay of elements such as iodine , uranium and plutonium . [ 68 ] Isotopes and isotopic studies [ edit ] Main article: Isotopes of xenon Naturally occurring xenon is made of eight stable isotopes , the most of any element with the exception of tin , which has ten. Xenon and tin are the only elements to have more than seven stable isotopes. [ 69 ] The isotopes 124 Xe and 134 Xe are predicted to undergo double beta decay , but this has never been observed so they are considered to be stable. [ 70 ] Besides these stable forms, there are over 40 unstable isotopes that have been studied. The longest lived of these isotopes is 136 Xe, which has been observed to undergo double beta decay with a half-life of 2.11 x 10 21 yr . [ 71 ] 129 Xe is produced by beta decay of 129 I , which has a half-life of 16 million years, while 131m Xe, 133 Xe, 133m Xe, and 135 Xe are some of the fission products of both 235 U and 239 Pu , [ 68 ] and therefore used as indicators of nuclear explosions. Nuclei of two of the stable isotopes of xenon , 129 Xe and 131 Xe, have non-zero intrinsic angular momenta ( nuclear spins , suitable for nuclear magnetic resonance ). The nuclear spins can be aligned beyond ordinary polarization levels by means of circularly polarized light and rubidium vapor. [ 72 ] The resulting spin polarization of xenon nuclei can surpass 50% of its maximum possible value, greatly exceeding the thermal equilibrium value dictated by paramagnetic statistics (typically 0.001% of the maximum value at room temperature , even in the strongest magnets ). Such non-equilibrium alignment of spins is a temporary condition, and is called hyperpolarization . The process of hyperpolarizing the xenon is called optical pumping (although the process is different from pumping a laser ). [ 73 ] Because a 129 Xe nucleus has a spin of 1/2, and therefore a zero electric quadrupole moment , the 129 Xe nucleus does not experience any quadrupolar interactions during collisions with other atoms, and thus its hyperpolarization can be maintained for long periods of time even after the laser beam has been turned off and the alkali vapor removed by condensation on a room-temperature surface. Spin polarization of 129 Xe can persist from several seconds for xenon atoms dissolved in blood [ 74 ] to several hours in the gas phase [ 75 ] and several days in deeply frozen solid xenon. [ 76 ] In contrast, 131 Xe has a nuclear spin value of 3 ⁄ 2 and a nonzero quadrupole moment , and has t 1 relaxation times in the millisecond and second ranges. [ 77 ] Some radioactive isotopes of xenon, for example, 133 Xe and 135 Xe, are produced by neutron irradiation of fissionable material within nuclear reactors . [ 11 ] 135 Xe is of considerable significance in the operation of nuclear fission reactors . 135 Xe has a huge cross section for thermal neutrons , 2.6×10 6 barns , [ 15 ] so it acts as a neutron absorber or " poison " that can slow or stop the chain reaction after a period of operation. This was discovered in the earliest nuclear reactors built by the American Manhattan Project for plutonium production. Fortunately the designers had made provisions in the design to increase the reactor's reactivity (the number of neutrons per fission that go on to fission other atoms of nuclear fuel ). [ 78 ] 135 Xe reactor poisoning played a major role in the Chernobyl disaster . [ 79 ] A shutdown or decrease of power of a reactor can result in buildup of 135 Xe and getting the reactor into the iodine pit . Under adverse conditions, relatively high concentrations of radioactive xenon isotopes may be found emanating from nuclear reactors due to the release of fission products from cracked fuel rods , [ 80 ] or fissioning of uranium in cooling water . [ 81 ] Because xenon is a tracer for two parent isotopes, xenon isotope ratios in meteorites are a powerful tool for studying the formation of the solar system . The iodine-xenon method of dating gives the time elapsed between nucleosynthesis and the condensation of a solid object from the solar nebula . In 1960, physicist John H. Reynolds discovered that certain meteorites contained an isotopic anomaly in the form of an overabundance of xenon-129. He inferred that this was a decay product of radioactive iodine-129 . This isotope is produced slowly by cosmic ray spallation and nuclear fission , but is produced in quantity only in supernova explosions. As the half-life of 129 I is comparatively short on a cosmological time scale, only 16 million years, this demonstrated that only a short time had passed between the supernova and the time the meteorites had solidified and trapped the 129 I. These two events (supernova and solidification of gas cloud) were inferred to have happened during the early history of the Solar System , as the 129 I isotope was likely generated before the Solar System was formed, but not long before, and seeded the solar gas cloud with isotopes from a second source. This supernova source may also have caused collapse of the solar gas cloud. [ 82 ] [ 83 ] In a similar way, xenon isotopic ratios such as 129 Xe/ 130 Xe and 136 Xe/ 130 Xe are also a powerful tool for understanding planetary differentiation and early outgassing. [ 14 ] For example, The atmosphere of Mars shows a xenon abundance similar to that of Earth: 0.08 parts per million, [ 84 ] however Mars shows a higher proportion of 129 Xe than the Earth or the Sun. As this isotope is generated by radioactive decay, the result may indicate that Mars lost most of its primordial atmosphere, possibly within the first 100 million years after the planet was formed. [ 85 ] [ 86 ] In another example, excess 129 Xe found in carbon dioxide well gases from New Mexico was believed to be from the decay of mantle -derived gases soon after Earth's formation. [ 68 ] [ 87 ] Compounds [ edit ] See also: Category:Xenon compounds . After Neil Bartlett's discovery in 1962 that xenon can form chemical compounds, a large number of xenon compounds have been discovered and described. Almost all known xenon compounds contain the electronegative atoms fluorine or oxygen. [ 88 ] Halides [ edit ] Xenon tetrafluoride XeF 4 crystals, 1962 Three fluorides are known: XeF 2 , XeF 4 , and XeF 6 . XeF is theorized to be unstable. [ 89 ] The fluorides are the starting point for the synthesis of almost all xenon compounds. The solid, crystalline difluoride XeF 2 is formed when a mixture of fluorine and xenon gases is exposed to ultraviolet light. [ 90 ] Ordinary daylight is sufficient. [ 91 ] Long-term heating of XeF 2 at high temperatures under an NiF 2 catalyst yields XeF 6 . [ 92 ] Pyrolysis of XeF 6 in the presence of NaF yields high-purity XeF 4 . [ 93 ] The xenon fluorides behave as both fluoride acceptors and fluoride donors, forming salts that contain such cations as XeF + and Xe 2 F + 3 , and anions such as XeF − 5 , XeF − 7 , and XeF 2− 8 . The green, paramagnetic Xe + 2 is formed by the reduction of XeF 2 by xenon gas. [ 88 ] XeF 2 is also able to form coordination complexes with transition metal ions. Over 30 such complexes have been synthesized and characterized. [ 92 ] Whereas the xenon fluorides are well-characterized, the other halides are not known, the only exception being the dichloride, XeCl 2 . Xenon dichloride is reported to be an endothermic, colorless, crystalline compound that decomposes into the elements at 80 °C, formed by the high-frequency irradiation of a mixture of xenon, fluorine, and silicon or carbon tetrachloride . [ 94 ] However, doubt has been raised as to whether XeCl 2 is a real compound and not merely a van der Waals molecule consisting of weakly bound Xe atoms and Cl 2 molecules. [ 95 ] Theoretical calculations indicate that the linear molecule XeCl 2 is less stable than the van der Waals complex. [ 96 ] Oxides and oxohalides [ edit ] Three oxides of xenon are known: xenon trioxide ( XeO 3 ) and xenon tetroxide ( XeO 4 ), both of which are dangerously explosive and powerful oxidizing agents, and xenon dioxide (XeO 2 ), which was reported in 2011 with a coordination number of four. [ 97 ] XeO 2 forms when xenon tetrafluoride is poured over ice. Its crystal structure may allow it to replace silicon in silicate minerals. [ 98 ] The XeOO + cation has been identified by infrared spectroscopy in solid argon . [ 99 ] Xenon does not react with oxygen directly; the trioxide is formed by the hydrolysis of XeF 6 : [ 100 ] XeF 6 + 3 H 2 O → XeO 3 + 6 HF XeO 3 is weakly acidic, dissolving in alkali to form unstable xenate salts containing the HXeO − 4 anion. These unstable salts easily disproportionate into xenon gas and perxenate salts, containing the XeO 4− 6 anion. [ 101 ] Barium perxenate, when treated with concentrated sulfuric acid , yields gaseous xenon tetroxide: [ 94 ] Ba 2 XeO 6 + 2 H 2 SO 4 → 2 BaSO 4 + 2 H 2 O + XeO 4 To prevent decomposition, the xenon tetroxide thus formed is quickly cooled to form a pale-yellow solid. It explodes above −35.9 °C into xenon and oxygen gas. A number of xenon oxyfluorides are known, including XeOF 2 , XeOF 4 , XeO 2 F 2 , and XeO 3 F 2 . XeOF 2 is formed by the reaction of OF 2 with xenon gas at low temperatures. It may also be obtained by the partial hydrolysis of XeF 4 . It disproportionates at −20 °C into XeF 2 and XeO 2 F 2 . [ 102 ] XeOF 4 is formed by the partial hydrolysis of XeF 6 , [ 103 ] or the reaction of XeF 6 with sodium perxenate, Na 4 XeO 6 . The latter reaction also produces a small amount of XeO 3 F 2 . XeOF 4 reacts with CsF to form the XeOF − 5 anion, [ 102 ] [ 104 ] while XeOF 3 reacts with the alkali metal fluorides KF , RbF and CsF to form the XeOF − 4 anion. [ 105 ] Other compounds [ edit ] Recently, there has been an interest in xenon compounds where xenon is directly bonded to a less electronegative element than fluorine or oxygen, particularly carbon . [ 106 ] Electron-withdrawing groups, such as groups with fluorine substitution, are necessary to stabilize these compounds. [ 101 ] Numerous such compounds have been characterized, including: [ 102 ] [ 107 ] C 6 F 5 –Xe + –N≡C–CH 3 , where C 6 F 5 is the pentafluorophenyl group. [C 6 F 5 ] 2 Xe C 6 F 5 –Xe–X , where X is CN , F, or Cl. R–C≡C–Xe + , where R is C 2 F − 5 or tert -butyl . C 6 F 5 –XeF + 2 (C 6 F 5 Xe) 2 Cl + Other compounds containing xenon bonded to a less electronegative element include F–Xe–N(SO 2 F) 2 and F–Xe–BF 2 . The latter is synthesized from dioxygenyl tetrafluoroborate, O 2 BF 4 , at −100 °C. [ 102 ] [ 108 ] An unusual ion containing xenon is the tetraxenonogold(II) cation, AuXe 2+ 4 , which contains Xe–Au bonds. [ 109 ] This ion occurs in the compound AuXe 4 (Sb 2 F 11 ) 2 , and is remarkable in having direct chemical bonds between two notoriously unreactive atoms, xenon and gold , with xenon acting as a transition metal ligand. The compound Xe 2 Sb 2 F 11 contains a Xe–Xe bond, the longest element-element bond known (308.71 pm = 3.0871 Å ). [ 110 ] In 1995, M. Räsänen and co-workers, scientists at the University of Helsinki in Finland , announced the preparation of xenon dihydride (HXeH), and later xenon hydride-hydroxide (HXeOH), hydroxenoacetylene (HXeCCH), and other Xe-containing molecules. [ 111 ] In 2008, Khriachtchev et al. reported the preparation of HXeOXeH by the photolysis of water within a cryogenic xenon matrix. [ 112 ] Deuterated molecules, HXeOD and DXeOH, have also been produced. [ 113 ] Clathrates and excimers [ edit ] In addition to compounds where xenon forms a chemical bond , xenon can form clathrates —substances where xenon atoms or pairs are trapped by the crystalline lattice of another compound. One example is xenon hydrate (Xe•5.75 H 2 O), where xenon atoms occupy vacancies in a lattice of water molecules. [ 114 ] This clathrate has a melting point of 24 °C. [ 115 ] The deuterated version of this hydrate has also been produced. [ 116 ] Another example is Xe hydride (Xe(H 2 ) 8 ), in which xenon pairs (dimers) are trapped inside solid hydrogen . [ 117 ] Such clathrate hydrates can occur naturally under conditions of high pressure, such as in Lake Vostok underneath the Antarctic ice sheet. [ 118 ] Clathrate formation can be used to fractionally distill xenon, argon and krypton. [ 119 ] Xenon can also form endohedral fullerene compounds, where a xenon atom is trapped inside a fullerene molecule. The xenon atom trapped in the fullerene can be monitored via 129 Xe nuclear magnetic resonance (NMR) spectroscopy. Using this technique, chemical reactions on the fullerene molecule can be analyzed, due to the sensitivity of the chemical shift of the xenon atom to its environment. However, the xenon atom also has an electronic influence on the reactivity of the fullerene. [ 120 ] When xenon atoms are at their ground energy state , they repel each other and will not form a bond. When xenon atoms becomes energized, however, they can form an excimer (excited dimer) until the electrons return to the ground state . This entity is formed because the xenon atom tends to fill its outermost electronic shell , and can briefly do this by adding an electron from a neighboring xenon atom. The typical lifetime of a xenon excimer is 1–5 ns, and the decay releases photons with wavelengths of about 150 and 173 nm . [ 121 ] [ 122 ] Xenon can also form excimers with other elements, such as the halogens bromine , chlorine and fluorine . [ 123 ] Applications [ edit ] Although xenon is rare and relatively expensive to extract from the Earth's atmosphere , it has a number of applications. Illumination and optics [ edit ] Gas-discharge lamps [ edit ] Xenon is used in light-emitting devices called xenon flash lamps, which are used in photographic flashes and stroboscopic lamps; [ 16 ] to excite the active medium in lasers which then generate coherent light ; [ 124 ] and, occasionally, in bactericidal lamps. [ 125 ] The first solid-state laser , invented in 1960, was pumped by a xenon flash lamp, [ 20 ] and lasers used to power inertial confinement fusion are also pumped by xenon flash lamps. [ 126 ] Xenon short-arc lamp Space Shuttle Atlantis bathed in xenon lights Xenon gas discharge tube Continuous, short-arc, high pressure xenon arc lamps have a color temperature closely approximating noon sunlight and are used in solar simulators . That is, the chromaticity of these lamps closely approximates a heated black body radiator that has a temperature close to that observed from the Sun. After they were first introduced during the 1940s, these lamps began replacing the shorter-lived carbon arc lamps in movie projectors. [ 17 ] They are employed in typical 35mm , IMAX and the new digital projectors film projection systems, automotive HID headlights, high-end "tactical" flashlights and other specialized uses. These arc lamps are an excellent source of short wavelength ultraviolet radiation and they have intense emissions in the near infrared , which is used in some night vision systems. The individual cells in a plasma display use a mixture of xenon and neon that is converted into a plasma using electrodes . The interaction of this plasma with the electrodes generates ultraviolet photons , which then excite the phosphor coating on the front of the display. [ 127 ] [ 128 ] Xenon is used as a "starter gas" in high pressure sodium lamps . It has the lowest thermal conductivity and lowest ionization potential of all the non-radioactive noble gases. As a noble gas, it does not interfere with the chemical reactions occurring in the operating lamp. The low thermal conductivity minimizes thermal losses in the lamp while in the operating state, and the low ionization potential causes the breakdown voltage of the gas to be relatively low in the cold state, which allows the lamp to be more easily started. [ 129 ] Lasers [ edit ] In 1962, a group of researchers at Bell Laboratories discovered laser action in xenon, [ 130 ] and later found that the laser gain was improved by adding helium to the lasing medium. [ 131 ] [ 132 ] The first excimer laser used a xenon dimer (Xe 2 ) energized by a beam of electrons to produce stimulated emission at an ultraviolet wavelength of 176 nm . [ 19 ] Xenon chloride and xenon fluoride have also been used in excimer (or, more accurately, exciplex) lasers. [ 133 ] The xenon chloride excimer laser has been employed, for example, in certain dermatological uses. [ 134 ] Medical [ edit ] Anesthesia [ edit ] Xenon has been used as a general anesthetic . Although it is expensive, anesthesia machines that can deliver xenon are about to appear on the European market, because advances in recovery and recycling of xenon have made it economically viable. [ 135 ] [ 136 ] Xenon interacts with many different receptors and ion channels and like many theoretically multi-modal inhalation anesthetics these interactions are likely complementary. Xenon is a high-affinity glycine-site NMDA receptor antagonist . [ 137 ] However, xenon distinguishes itself from other clinically used NMDA receptor antagonists in its lack of neurotoxicity and its ability to inhibit the neurotoxicity of ketamine and nitrous oxide . [ 138 ] [ 139 ] Unlike ketamine and nitrous oxide, xenon does not stimulate a dopamine efflux in the nucleus accumbens . [ 140 ] Like nitrous oxide and cyclopropane, xenon activates the two-pore domain potassium channel TREK-1 . A related channel TASK-3 also implicated in inhalational anesthetic actions is insensitive to xenon. [ 141 ] Xenon inhibits nicotinic acetylcholine α 4 β 2 receptors which contribute to spinally mediated analgesia. [ 142 ] [ 143 ] Xenon is an effective inhibitor of plasma membrane Ca 2+ ATPase . Xenon inhibits Ca 2+ ATPase by binding to a hydrophobic pore within the enzyme and preventing the enzyme from assuming active conformations. [ 144 ] Xenon is a competitive inhibitor of the serotonin 5-HT 3 receptor . While neither anesthetic nor antinociceptive this activity reduces anesthesia-emergent nausea and vomiting. [ 145 ] Xenon has a minimum alveolar concentration (MAC) of 72% at age 40, making it 44% more potent than N 2 O as an anesthetic. [ 146 ] Thus it can be used in concentrations with oxygen that have a lower risk of hypoxia . Unlike nitrous oxide (N 2 O), xenon is not a greenhouse gas and so it is also viewed as environmentally friendly . [ 147 ] Xenon vented into the atmosphere is being returned to its original source, so no environmental impact is likely. Neuroprotectant [ edit ] Xenon induces robust cardioprotection and neuroprotection through a variety of mechanisms of action. Through its influence on Ca2+, K+, KATP\HIF and NMDA antagonism xenon is neuroprotective when administered before, during and after ischemic insults. [ 148 ] [ 149 ] Xenon is a high affinity antagonist at the NMDA receptor glycine site. [ 137 ] Xenon is cardioprotective in ischemia-reperfusion conditions by inducing pharmacologic non-ischemic preconditioning. Xenon is cardioprotective by activating PKC-epsilon & downstream p38-MAPK. [ 150 ] Xenon mimics neuronal ischemic preconditioning by activating ATP sensitive potassium channels. [ 151 ] Xenon allosterically reduces ATP mediated channel activation inhibition independently of the sulfonylurea receptor1 subunit, increasing KATP open-channel time and frequency. [ 152 ] Xenon upregulates hypoxia inducible factor 1 alpha (HIF1a). Xenon gas was added as an ingredient of the ventilation mix for a newborn baby at St. Michael's Hospital, Bristol , England, whose life chances were otherwise very compromised, and was successful, leading to the authorisation of clinical trials for similar cases. [ 153 ] The treatment is done simultaneously with cooling the body temperature to 33.5 °C . [ 154 ] Doping [ edit ] Inhaling a xenon/oxygen mixture activates production of the transcription factor HIF-1-alpha , which leads to increased production of erythropoietin . The latter hormone is known to increase red blood cell production and athletes' performance. Xenon inhalation has been used for this purpose in Russia since at least 2004. [ 155 ] On August 31 2014 the World Anti Doping Agency (WADA) added Xenon (and Argon ) to the list of prohibited substances and methods, although at this time there is no reliable drug test. [ 156 ] Imaging [ edit ] Gamma emission from the radioisotope 133 Xe of xenon can be used to image the heart, lungs, and brain, for example, by means of single photon emission computed tomography . 133 Xe has also been used to measure blood flow . [ 157 ] [ 158 ] [ 159 ] Xenon, particularly hyperpolarized 129 Xe, is a useful contrast agent for magnetic resonance imaging (MRI). In the gas phase, it can be used to image empty space such as cavities in a porous sample or alveoli in lungs. Hyperpolarization renders 129 Xe much more detectable via magnetic resonance imaging and has been used for studies of the lungs and other tissues. It can be used, for example, to trace the flow of gases within the lungs. [ 160 ] [ 161 ] Because xenon is soluble in water and also in hydrophobic solvents, it can be used to image various soft living tissues. [ 162 ] [ 163 ] [ 164 ] Xenon with its high nuclear mass is a useful contrast medium for x-ray photography. For this purpose it is supplemented by Krypton and used at concentrations below 35% as otherwise it would act as a narcotic . NMR spectroscopy [ edit ] Because of the xenon atom's large, flexible outer electron shell, the NMR spectrum changes in response to surrounding conditions, and can therefore be used as a probe to measure the chemical circumstances around it. For instance xenon dissolved in water, xenon dissolved in hydrophobic solvent, and xenon associated with certain proteins can be distinguished by NMR. [ 165 ] [ 166 ] Hyperpolarized xenon can be used by surface chemists . Normally, it is difficult to characterize surfaces using NMR, because signals from the surface of a sample will be overwhelmed by signals from the far-more-numerous atomic nuclei in the bulk. However, nuclear spins on solid surfaces can be selectively polarized, by transferring spin polarization to them from hyperpolarized xenon gas. This makes the surface signals strong enough to measure, and distinguishes them from bulk signals. [ 167 ] [ 168 ] Other [ edit ] In nuclear energy applications, xenon is used in bubble chambers , [ 169 ] probes, and in other areas where a high molecular weight and inert nature is desirable. A by-product of nuclear weapon testing is the release of radioactive xenon-133 and xenon-135. The detection of these isotopes is used to monitor compliance with nuclear test ban treaties , [ 170 ] as well as to confirm nuclear test explosions by states such as North Korea . [ 171 ] A prototype of a xenon ion engine being tested at NASA's Jet Propulsion Laboratory . Liquid xenon is being used in calorimeters [ 172 ] for measurements of gamma rays as well as a medium for detecting hypothetical weakly interacting massive particles , or WIMPs. When a WIMP collides with a xenon nucleus, it is predicted to impart enough energy to cause ionization and scintillation . Liquid xenon is useful for this type of experiment due to its high density which makes dark matter interaction more likely and permits a quiet detector due to self-shielding. Xenon is the preferred propellant for ion propulsion of spacecraft because of its low ionization potential per atomic weight , and its ability to be stored as a liquid at near room temperature (under high pressure) yet be easily converted back into a gas to feed the engine. The inert nature of xenon makes it environmentally friendly and less corrosive to an ion engine than other fuels such as mercury or caesium . Xenon was first used for satellite ion engines during the 1970s. [ 173 ] It was later employed as a propellant for JPL's Deep Space 1 probe, Europe's SMART-1 spacecraft [ 22 ] and for the three ion propulsion engines on NASA's Dawn Spacecraft . [ 174 ] Chemically, the perxenate compounds are used as oxidizing agents in analytical chemistry . Xenon difluoride is used as an etchant for silicon , particularly in the production of microelectromechanical systems (MEMS). [ 175 ] The anticancer drug 5-fluorouracil can be produced by reacting xenon difluoride with uracil . [ 176 ] Xenon is also used in protein crystallography . Applied at pressures from 0.5 to 5 MPa (5 to 50 atm ) to a protein crystal, xenon atoms bind in predominantly hydrophobic cavities, often creating a high-quality, isomorphous, heavy-atom derivative, which can be used for solving the phase problem . [ 177 ] [ 178 ] Precautions [ edit ] Many oxygen-containing xenon compounds are toxic due to their strong oxidative properties, and explosive due to their tendency to break down into elemental xenon plus diatomic oxygen (O 2 ), which contains much stronger chemical bonds than the xenon compounds. [ 179 ] Xenon gas can be safely kept in normal sealed glass or metal containers at standard temperature and pressure . However, it readily dissolves in most plastics and rubber, and will gradually escape from a container sealed with such materials. [ 180 ] Xenon is non- toxic , although it does dissolve in blood and belongs to a select group of substances that penetrate the blood–brain barrier , causing mild to full surgical anesthesia when inhaled in high concentrations with oxygen. [ 179 ] At 169 m/s, the speed of sound in xenon gas is slower than that in air [ 181 ] due to the slower average speed of the heavy xenon atoms compared to nitrogen and oxygen molecules. Hence, xenon lowers the rate of vibration in the vocal tract when exhaled. This produces a characteristic lowered voice timbre, an effect opposite to the high-timbred voice caused by inhalation of helium . Like helium, xenon does not satisfy the body's need for oxygen. Xenon is both a simple asphyxiant and an anesthetic more powerful than nitrous oxide; consequently, many universities no longer allow the voice stunt as a general chemistry demonstration. As xenon is expensive, the gas sulfur hexafluoride , which is similar to xenon in molecular weight (146 versus 131), is generally used in this stunt, and is an asphyxiant without being anesthetic. [ 182 ] It is possible to safely breathe dense gases such as xenon or sulfur hexafluoride when they are in a mixture of at least 20% oxygen. Xenon at 80% concentration along with 20% oxygen rapidly produces the unconsciousness of general anesthesia (and has been used for this, as discussed above). Breathing mixes gases of different densities very effectively and rapidly so that heavier gases are purged along with the oxygen, and do not accumulate at the bottom of the lungs. [ 183 ] There is, however, a danger associated with any heavy gas in large quantities: it may sit invisibly in a container, and if a person enters a container filled with an odorless, colorless gas, they may find themselves breathing it unknowingly. Xenon is rarely used in large enough quantities for this to be a concern, though the potential for danger exists any time a tank or container of xenon is kept in an unventilated space. [ 184 ] See also [ edit ] Chemistry portal Buoyant levitation Penning mixture Xenon Period 5 elements Noble gases Chemical elements (sorted alphabetically) Chemical elements (sorted by number) References [ edit ] ^ Simpson, J. A.; Weiner, E. S. C., eds. (1989). "Xenon". Oxford English Dictionary 20 (2nd ed.). Clarendon Press . ISBN 0-19-861232-X . ^ "Xenon" . Dictionary.com Unabridged . 2010 . Retrieved 2010-05-06 . ^ Standard Atomic Weights 2013 . Commission on Isotopic Abundances and Atomic Weights ^ "Xenon" . Gas Encyclopedia . Air Liquide . 2009. ^ a b Haynes, William M., ed. (2011). CRC Handbook of Chemistry and Physics (92nd ed.). Boca Raton, FL: CRC Press . p. 4.123. ISBN 1439855110 . ^ Hwang, Shuen-Cheng; Weltmer, William R. (2000). "Helium Group Gases". Kirk-Othmer Encyclopedia of Chemical Technology . Wiley. pp. 343–383. doi : 10.1002/0471238961.0701190508230114.a01 . ISBN 0-471-23896-1 . ^ Magnetic susceptibility of the elements and inorganic compounds , in Lide, D. R., ed. (2005). CRC Handbook of Chemistry and Physics (86th ed.). Boca Raton (FL): CRC Press. ISBN 0-8493-0486-5 . ^ Albert, J. B.; Auger, M.; Auty, D. J.; Barbeau, P. S.; Beauchamp, E.; Beck, D.; Belov, V.; Benitez-Medina, C.; Bonatt, J.; Breidenbach, M.; Brunner, T.; Burenkov, A.; Cao, G. F.; Chambers, C.; Chaves, J.; Cleveland, B.; Cook, S.; Craycraft, A.; Daniels, T.; Danilov, M.; Daugherty, S. J.; Davis, C. G.; Davis, J.; Devoe, R.; Delaquis, S.; Dobi, A.; Dolgolenko, A.; Dolinski, M. J.; Dunford, M.; et al. (2014). "Improved measurement of the 2νββ half-life of 136 Xe with the EXO-200 detector". Physical Review C 89 . doi : 10.1103/PhysRevC.89.015502 . ^ Redshaw, M.; Wingfield, E.; McDaniel, J.; Myers, E. (2007). "Mass and Double-Beta-Decay Q Value of 136 Xe". Physical Review Letters 98 (5): 53003. Bibcode : 2007PhRvL..98e3003R . doi : 10.1103/PhysRevLett.98.053003 . ^ Staff (2007). "Xenon" . Columbia Electronic Encyclopedia (6th ed.). Columbia University Press . Retrieved 2007-10-23 . ^ a b Husted, Robert; Boorman, Mollie (December 15, 2003). "Xenon" . Los Alamos National Laboratory , Chemical Division . Retrieved 2007-09-26 . ^ Rabinovich, Viktor Abramovich; Vasserman, A. A.; Nedostup, V. I.; Veksler, L. S. (1988). Thermophysical properties of neon, argon, krypton, and xenon (English-language ed.). Washington, DC: Hemisphere Publishing Corp. Bibcode : 1988wdch...10.....R . ISBN 0-89116-675-0 . Retrieved 2009-04-02 . —National Standard Reference Data Service of the USSR. Volume 10. ^ a b Freemantel, Michael (August 25, 2003). "Chemistry at its Most Beautiful" (PDF) . Chemical & Engineering News . Retrieved 2007-09-13 . ^ a b Kaneoka, Ichiro (1998). "Xenon's Inside Story". Science 280 (5365): 851–852. doi : 10.1126/science.280.5365.851b . ^ a b Stacey, Weston M. (2007). Nuclear Reactor Physics . Wiley-VCH. p. 213. ISBN 3-527-40679-4 . ^ a b c Burke, James (2003). Twin Tracks: The Unexpected Origins of the Modern World . Oxford University Press. p. 33. ISBN 0-7432-2619-4 . ^ a b Mellor, David (2000). Sound Person's Guide to Video . Focal Press . p. 186. ISBN 0-240-51595-1 . ^ Sanders, Robert D.; Ma, Daqing; Maze, Mervyn (2005). "Xenon: elemental anaesthesia in clinical practice". British Medical Bulletin 71 (1): 115–35. doi : 10.1093/bmb/ldh034 . PMID 15728132 . ^ a b Basov, N. G.; Danilychev, V. A.; Popov, Yu. M. (1971). "Stimulated Emission in the Vacuum Ultraviolet Region". Soviet Journal of Quantum Electronics 1 (1): 18–22. Bibcode : 1971QuEle...1...18B . doi : 10.1070/QE1971v001n01ABEH003011 . ^ a b Toyserkani, E.; Khajepour, A.; Corbin, S. (2004). Laser Cladding . CRC Press. p. 48. ISBN 0-8493-2172-7 . ^ Ball, Philip (May 1, 2002). "Xenon outs WIMPs" . Nature . Retrieved 2007-10-08 . ^ a b Saccoccia, G.; del Amo, J. G.; Estublier, D. (August 31, 2006). "Ion engine gets SMART-1 to the Moon" . ESA . Retrieved 2007-10-01 . ^ Ramsay, Sir William (December 12, 1904). "Nobel Lecture - The Rare Gases of the Atmosphere" . nobelprize.org . Nobel Media AB . Retrieved 15 November 2015 . ^ Ramsay, W.; Travers, M. W. (1898). "On the extraction from air of the companions of argon, and neon". Report of the Meeting of the British Association for the Advancement of Science : 828. ^ Gagnon, Steve. "It's Elemental – Xenon" . Thomas Jefferson National Accelerator Facility . Retrieved 2007-06-16 . ^ Anonymous (1904). Daniel Coit Gilman; Harry Thurston Peck; Frank Moore Colby, eds. The New International Encyclopædia . Dodd, Mead and Company . p. 906. ^ Staff (1991). The Merriam-Webster New Book of Word Histories . Merriam-Webster, Inc. p. 513. ISBN 0-87779-603-3 . ^ Ramsay, William (1902). "An Attempt to Estimate the Relative Amounts of Krypton and of Xenon in Atmospheric Air". Proceedings of the Royal Society of London 71 (467–476): 421–426. doi : 10.1098/rspl.1902.0121 . ^ Anonymous. "History" . Millisecond Cinematography. Archived from the original on 2006-08-22 . Retrieved 2007-11-07 . ^ Paschotta, Rüdiger (November 1, 2007). "Lamp-pumped lasers" . Encyclopedia of Laser Physics and Technology . RP Photonics . Retrieved 2007-11-07 . ^ Marx, Thomas; Schmidt, Michael; Schirmer, Uwe; Reinelt, Helmut (2000). "Xenon anesthesia" (PDF) . Journal of the Royal Society of Medicine 93 (10): 513–7. PMC 1298124 . PMID 11064688 . Retrieved 2007-10-02 . ^ Bartlett, Neil; Lohmann, D. H. (1962). "Dioxygenyl hexafluoroplatinate (V), O 2 + [PtF 6 ] − ". Proceedings of the Chemical Society (London: Chemical Society) (3): 115. doi : 10.1039/PS9620000097 . ^ Bartlett, N. (1962). "Xenon hexafluoroplatinate (V) Xe + [PtF 6 ] − ". Proceedings of the Chemical Society (London: Chemical Society ) (6): 218. doi : 10.1039/PS9620000197 . ^ Graham, L.; Graudejus, O.; Jha N.K.; Bartlett, N. (2000). "Concerning the nature of XePtF 6 ". Coordination Chemistry Reviews 197 (1): 321–334. doi : 10.1016/S0010-8545(99)00190-3 . ^ Holleman, A. F.; Wiberg, Egon (2001). Bernhard J. Aylett, ed. Inorganic Chemistry . translated by Mary Eagleson and William Brewer. San Diego: Academic Press . ISBN 0-12-352651-5 . ; translation of Lehrbuch der Anorganischen Chemie , originally founded by A. F. Holleman, continued by Egon Wiberg , edited by Nils Wiberg, Berlin: de Gruyter, 1995, 34th edition, ISBN 3-11-012641-9 . ^ Steel, Joanna (2007). "Biography of Neil Bartlett" . College of Chemistry, University of California, Berkeley . Retrieved 2007-10-25 . ^ Bartlett, Neil (2003-09-09). "The Noble Gases" . Chemical & Engineering News (American Chemical Society) 81 (36) . Retrieved 2007-10-01 . ^ Khriachtchev, Leonid; Pettersson, Mika; Runeberg, Nino; Lundell, Jan; Räsänen, Markku (2000-08-24). "A stable argon compound" . Nature 406 (6798): 874–6. doi : 10.1038/35022551 . PMID 10972285 . Retrieved 2008-06-04 . ^ Lynch, C. T.; Summitt, R.; Sliker, A. (1980). CRC Handbook of Materials Science . CRC Press . ISBN 0-87819-231-X . ^ MacKenzie, D. R. (1963). "Krypton Difluoride: Preparation and Handling". Science 141 (3586): 1171. Bibcode : 1963Sci...141.1171M . doi : 10.1126/science.141.3586.1171 . PMID 17751791 . ^ Paul R. Fields; Lawrence Stein & Moshe H. Zirin (1962). "Radon Fluoride". Journal of the American Chemical Society 84 (21): 4164–4165. doi : 10.1021/ja00880a048 . ^ "Xenon" . Periodic Table Online . CRC Press. Archived from the original on April 10, 2007 . Retrieved 2007-10-08 . ^ Moody, G. J. (1974). "A Decade of Xenon Chemistry" . Journal of Chemical Education 51 (10): 628–630. Bibcode : 1974JChEd..51..628M . doi : 10.1021/ed051p628 . Retrieved 2007-10-16 . ^ Browne, Malcolm W. (April 5, 1990) "2 Researchers Spell 'I.B.M.,' Atom by Atom" . New York Times ^ Williams, David R. (April 19, 2007). "Earth Fact Sheet" . NASA . Retrieved 2007-10-04 . ^ a b Aprile, Elena; Bolotnikov, Aleksey E.; Doke, Tadayoshi (2006). Noble Gas Detectors . Wiley-VCH . pp. 8–9. ISBN 3-527-60963-6 . ^ Rentzepis, P. M.; Douglass, D. C. (1981-09-10). "Xenon as a solvent" . Nature 293 (5828): 165–166. doi : 10.1038/293165a0 . ^ Caldwell, W. A.; Nguyen, J.; Pfrommer, B.; Louie, S.; Jeanloz, R. (1997). "Structure, bonding and geochemistry of xenon at high pressures". Science 277 (5328): 930–933. doi : 10.1126/science.277.5328.930 . ^ Fontes, E. "Golden Anniversary for Founder of High-pressure Program at CHESS" . Cornell University . Retrieved 2009-05-30 . ^ Eremets, Mikhail I.; Gregoryanz, Eugene A.; Struzhkin, Victor V.; Mao, Ho-Kwang; Hemley, Russell J.; Mulders, Norbert; Zimmerman, Neil M. (2000). "Electrical Conductivity of Xenon at Megabar Pressures". Physical Review Letters 85 (13): 2797–800. Bibcode : 2000PhRvL..85.2797E . doi : 10.1103/PhysRevLett.85.2797 . PMID 10991236 . ^ Iakoubovskii, Konstantin; Mitsuishi, Kazutaka; Furuya, Kazuo (2008). "Structure and pressure inside Xe nanoparticles embedded in Al". Physical Review B 78 (6). doi : 10.1103/PhysRevB.78.064105 . ^ Bader, Richard F. W. "An Introduction to the Electronic Structure of Atoms and Molecules" . McMaster University . Retrieved 2007-09-27 . ^ Talbot, John. "Spectra of Gas Discharges" . Rheinisch-Westfälische Technische Hochschule Aachen . Retrieved 2006-08-10 . ^ Watts, William Marshall (1904). An Introduction to the Study of Spectrum Analysis . London: Longmans, Green, and Co. ^ Hwang, Shuen-Cheng; Robert D. Lein; Daniel A. Morgan (2005). "Noble Gases". Kirk-Othmer Encyclopedia of Chemical Technology (5th ed.). Wiley . doi : 10.1002/0471238961.0701190508230114.a01 . ISBN 0-471-48511-X . ^ Kerry, Frank G. (2007). Industrial Gas Handbook: Gas Separation and Purification . CRC Press. pp. 101–103. ISBN 0-8493-9005-2 . ^ "Xenon – Xe" . CFC StarTec LLC. August 10, 1998 . Retrieved 2007-09-07 . ^ a b Häussinger, Peter; Glatthaar, Reinhard; Rhode, Wilhelm; Kick, Helmut; Benkmann, Christian; Weber, Josef; Wunschel, Hans-Jörg; Stenke, Viktor; Leicht, Edith; Stenger, Hermann (2001). "Noble Gases". Ullmann's Encyclopedia of Industrial Chemistry (6th ed.). Wiley. doi : 10.1002/14356007.a17_485 . ISBN 3-527-20165-3 . ^ Arnett, David (1996). Supernovae and Nucleosynthesis . Princeton, New Jersey: Princeton University Press . ISBN 0-691-01147-8 . ^ Mahaffy, P. R.; Niemann, H. B.; Alpert, A.; Atreya, S. K.; Demick, J.; Donahue, T. M.; Harpold, D. N.; Owen, T. C. (2000). "Noble gas abundance and isotope ratios in the atmosphere of Jupiter from the Galileo Probe Mass Spectrometer". Journal of Geophysical Research 105 (E6): 15061–15072. Bibcode : 2000JGR...10515061M . doi : 10.1029/1999JE001224 . ^ Mass fraction calculated from the average mass of an atom in the solar system of about 1.29 atomic mass units ^ Owen, Tobias; Mahaffy, Paul; Niemann, H. B.; Atreya, Sushil; Donahue, Thomas; Bar-Nun, Akiva; de Pater, Imke (1999). "A low-temperature origin for the planetesimals that formed Jupiter". Nature 402 (6759): 269–70. Bibcode : 1999Natur.402..269O . doi : 10.1038/46232 . PMID 10580497 . ^ Sanloup, Chrystèle; et al. (2005). "Retention of Xenon in Quartz and Earth's Missing Xenon". Science 310 (5751): 1174–7. Bibcode : 2005Sci...310.1174S . doi : 10.1126/science.1119070 . PMID 16293758 . ^ Clayton, Donald D. (1983). Principles of Stellar Evolution and Nucleosynthesis . University of Chicago Press . ISBN 0-226-10953-4 . ^ Heymann, D.; Dziczkaniec, M. (March 19–23, 1979). Xenon from intermediate zones of supernovae . Proceedings 10th Lunar and Planetary Science Conference (Houston, Texas: Pergamon Press, Inc.). pp. 1943–1959. Bibcode : 1979LPSC...10.1943H . ^ Beer, H.; Kaeppeler, F.; Reffo, G.; Venturini, G. (November 1983). "Neutron capture cross-sections of stable xenon isotopes and their application in stellar nucleosynthesis". Astrophysics and Space Science 97 (1): 95–119. Bibcode : 1983Ap&SS..97...95B . doi : 10.1007/BF00684613 . ^ Pignatari, M.; Gallino, R.; Straniero, O.; Davis, A. (2004). "The origin of xenon trapped in presolar mainstream SiC grains". Memorie della Societa Astronomica Italiana 75 : 729–734. Bibcode : 2004MmSAI..75..729P . ^ a b c Caldwell, Eric (January 2004). "Periodic Table – Xenon" . Resources on Isotopes . USGS . Retrieved 2007-10-08 . ^ Rajam, J. B. (1960). Atomic Physics (7th ed.). Delhi: S. Chand and Co. ISBN 81-219-1809-X . ^ Barabash, A. S. (2002). "Average (Recommended) Half-Life Values for Two-Neutrino Double-Beta Decay". Czechoslovak Journal of Physics 52 (4): 567–573. arXiv : nucl-ex/0203001 . Bibcode : 2002CzJPh..52..567B . doi : 10.1023/A:1015369612904 . ^ Ackerman, N. (2011). "Observation of Two-Neutrino Double-Beta Decay in 136 Xe with the EXO-200 Detector". Physical Review Letters 107 (21). Bibcode : 2011PhRvL.107u2501A . doi : 10.1103/PhysRevLett.107.212501 . ^ Otten, Ernst W. (2004). "Take a breath of polarized noble gas". Europhysics News 35 (1): 16–20. Bibcode : 2004ENews..35...16O . doi : 10.1051/epn:2004109 . ^ Ruset, I. C.; Ketel, S.; Hersman, F. W. (2006). "Optical Pumping System Design for Large Production of Hyperpolarized 129 Xe". Physical Review Letters 96 (5): 053002. Bibcode : 2006PhRvL..96e3002R . doi : 10.1103/PhysRevLett.96.053002 . ^ Wolber, J.; Cherubini, A.; Leach, M. O.; Bifone, A. (2000). "On the oxygenation-dependent 129 Xe t 1 in blood". NMR in Biomedicine 13 (4): 234–7. doi : 10.1002/1099-1492(200006)13:4<234::AID-NBM632>3.0.CO;2-K . PMID 10867702 . ^ Chann, B.; Nelson, I. A.; Anderson, L. W.; Driehuys, B.; Walker, T. G. (2002). " 129 Xe-Xe molecular spin relaxation". Physical Review Letters 88 (11): 113–201. Bibcode : 2002PhRvL..88k3201C . doi : 10.1103/PhysRevLett.88.113201 . ^ von Schulthess, Gustav Konrad; Smith, Hans-Jørgen; Pettersson, Holger; Allison, David John (1998). The Encyclopaedia of Medical Imaging . Taylor & Francis. p. 194. ISBN 1-901865-13-4 . ^ Warren, W. W.; Norberg, R. E. (1966). "Nuclear Quadrupole Relaxation and Chemical Shift of Xe 131 in Liquid and Solid Xenon". Physical Review 148 (1): 402–412. Bibcode : 1966PhRv..148..402W . doi : 10.1103/PhysRev.148.402 . ^ Staff. "Hanford Becomes Operational" . The Manhattan Project: An Interactive History . U.S. Department of Energy. Archived from the original on 2009-12-10 . Retrieved 2007-10-10 . ^ Pfeffer, Jeremy I.; Nir, Shlomo (2000). Modern Physics: An Introductory Text . Imperial College Press . pp. 421 ff. ISBN 1-86094-250-4 . ^ Laws, Edwards A. (2000). Aquatic Pollution: An Introductory Text . John Wiley and Sons. p. 505. ISBN 0-471-34875-9 . ^ Staff (April 9, 1979). "A Nuclear Nightmare" . Time . Retrieved 2007-10-09 . ^ Clayton, Donald D. (1983). Principles of Stellar Evolution and Nucleosynthesis (2nd ed.). University of Chicago Press. p. 75. ISBN 0-226-10953-4 . ^ Bolt, B. A.; Packard, R. E.; Price, P. B. (2007). "John H. Reynolds, Physics: Berkeley" . The University of California, Berkeley . Retrieved 2007-10-01 . ^ Williams, David R. (September 1, 2004). "Mars Fact Sheet" . NASA . Retrieved 2007-10-10 . ^ Schilling, James. "Why is the Martian atmosphere so thin and mainly carbon dioxide?" . Mars Global Circulation Model Group . Retrieved 2007-10-10 . ^ Zahnle, Kevin J. (1993). "Xenological constraints on the impact erosion of the early Martian atmosphere". Journal of Geophysical Research 98 (E6): 10,899–10,913. Bibcode : 1993JGR....9810899Z . doi : 10.1029/92JE02941 . ^ Boulos, M. S.; Manuel, O.K. (1971). "The xenon record of extinct radioactivities in the Earth". Science 174 (4016): 1334–6. Bibcode : 1971Sci...174.1334B . doi : 10.1126/science.174.4016.1334 . PMID 17801897 . ^ a b Harding, Charlie; Johnson, David Arthur; Janes, Rob (2002). Elements of the p block . Great Britain: Royal Society of Chemistry. pp. 93–94. ISBN 0-85404-690-9 . ^ Dean H Liskow; Henry F I I I Schaefer; Paul S Bagus; Bowen Liu (1973). "Probable nonexistence of xenon monofluoride as a chemically bound species in the gas phase". J Amer Chem Soc 95 (12): 4056–4057. doi : 10.1021/ja00793a042 . ^ Weeks, James L.; Chernick, Cedric; Matheson, Max S. (1962). "Photochemical Preparation of Xenon Difluoride". Journal of the American Chemical Society 84 (23): 4612–4613. doi : 10.1021/ja00882a063 . ^ Streng, L. V.; Streng, A. G. (1965). "Formation of Xenon Difluoride from Xenon and Oxygen Difluoride or Fluorine in Pyrex Glass at Room Temperature". Inorganic Chemistry 4 (9): 1370–1371. doi : 10.1021/ic50031a035 . ^ a b Tramšek, Melita; Žemva, Boris (December 5, 2006). "Synthesis, Properties and Chemistry of Xenon(II) Fluoride" (PDF) . Acta Chimica Slovenica 53 (2): 105–116. doi : 10.1002/chin.200721209 . Retrieved 2009-07-18 . ^ Ogrin, Tomaz; Bohinc, Matej; Silvnik, Joze (1973). "Melting-point determinations of xenon difluoride-xenon tetrafluoride mixtures". Journal of Chemical and Engineering Data 18 (4): 402. doi : 10.1021/je60059a014 . ^ a b Scott, Thomas; Eagleson, Mary (1994). "Xenon Compounds" . Concise encyclopedia chemistry . Walter de Gruyter . p. 1183. ISBN 3-11-011451-8 . ^ Proserpio, Davide M.; Hoffmann, Roald; Janda, Kenneth C. (1991). "The xenon-chlorine conundrum: van der Waals complex or linear molecule?". Journal of the American Chemical Society 113 (19): 7184–7189. doi : 10.1021/ja00019a014 . ^ Richardson, Nancy A.; Hall, Michael B. (1993). "The potential energy surface of xenon dichloride". The Journal of Physical Chemistry 97 (42): 10952–10954. doi : 10.1021/j100144a009 . ^ Brock, D.S.; Schrobilgen, G.J. (2011). "Synthesis of the missing oxide of xenon, XeO 2 , and its implications for earth's missing xenon". Journal of the American Chemical Society 133 (16): 6265–9. doi : 10.1021/ja110618g . PMID 21341650 . ^ "Chemistry: Where did the xenon go?". Nature 471 (7337): 138–138. 2011. doi : 10.1038/471138d . ^ Zhou, M.; Zhao, Y.; Gong, Y.; Li, J. (2006). "Formation and Characterization of the XeOO + Cation in Solid Argon". Journal of the American Chemical Society 128 (8): 2504–5. doi : 10.1021/ja055650n . PMID 16492012 . ^ Holloway, John H.; Hope, Eric G. (1998). A. G. Sykes, ed. Advances in Inorganic Chemistry Press . Academic. p. 65. ISBN 0-12-023646-X . ^ a b Henderson, W. (2000). Main group chemistry . Great Britain: Royal Society of Chemistry . pp. 152–153. ISBN 0-85404-617-8 . ^ a b c d Mackay, Kenneth Malcolm; Mackay, Rosemary Ann; Henderson, W. (2002). Introduction to modern inorganic chemistry (6th ed.). CRC Press. pp. 497–501. ISBN 0-7487-6420-8 . ^ Smith, D. F. (1963). "Xenon Oxyfluoride". Science 140 (3569): 899–900. Bibcode : 1963Sci...140..899S . doi : 10.1126/science.140.3569.899 . PMID 17810680 . ^ Christe, K. O.; Dixon, D. A.; Sanders, J. C. P.; Schrobilgen, G. J.; Tsai, S. S.; Wilson, W. W. (1995). "On the Structure of the [XeOF 5 ] − Anion and of Heptacoordinated Complex Fluorides Containing One or Two Highly Repulsive Ligands or Sterically Active Free Valence Electron Pairs". Inorg. Chem. 34 (7): 1868–1874. doi : 10.1021/ic00111a039 . ^ Christe, K. O.; Schack, C. J.; Pilipovich, D. (1972). "Chlorine trifluoride oxide. V. Complex formation with Lewis acids and bases". Inorg. Chem. 11 (9): 2205–2208. doi : 10.1021/ic50115a044 . ^ Holloway, John H.; Hope, Eric G. (1998). Advances in Inorganic Chemistry . Contributor A. G. Sykes. Academic Press. pp. 61–90. ISBN 0-12-023646-X . ^ Frohn, H; Theißen, Michael (2004). "C 6 F 5 XeF, a versatile starting material in xenon–carbon chemistry". Journal of Fluorine Chemistry 125 (6): 981–988. doi : 10.1016/j.jfluchem.2004.01.019 . ^ Goetschel, Charles T.; Loos, Karl R. (1972). "Reaction of xenon with dioxygenyl tetrafluoroborate. Preparation of FXe-BF 2 ". Journal of the American Chemical Society 94 (9): 3018–3021. doi : 10.1021/ja00764a022 . ^ Li, Wai-Kee; Zhou, Gong-Du; Mak, Thomas C. W. (2008). Gong-Du Zhou; Thomas C. W. Mak, eds. Advanced Structural Inorganic Chemistry . Oxford University Press . p. 678. ISBN 0-19-921694-0 . ^ Li, Wai-Kee; Zhou, Gong-Du; Mak, Thomas C. W. (2008). Advanced Structural Inorganic Chemistry . Oxford University Press. p. 674. ISBN 0-19-921694-0 . ^ Gerber, R. B. (2004). "Formation of novel rare-gas molecules in low-temperature matrices". Annual Review of Physical Chemistry 55 (1): 55–78. Bibcode : 2004ARPC...55...55G . doi : 10.1146/annurev.physchem.55.091602.094420 . PMID 15117247 . ^ Khriachtchev, Leonid; Isokoski, Karoliina; Cohen, Arik; Räsänen, Markku; Gerber, R. Benny (2008). "A Small Neutral Molecule with Two Noble-Gas Atoms: HXeOXeH". Journal of the American Chemical Society 130 (19): 6114–8. doi : 10.1021/ja077835v . PMID 18407641 . ^ Pettersson, Mika; Khriachtchev, Leonid; Lundell, Jan; Räsänen, Markku (1999). "A Chemical Compound Formed from Water and Xenon: HXeOH". Journal of the American Chemical Society 121 (50): 11904–11905. doi : 10.1021/ja9932784 . ^ Pauling, L. (1961). "A molecular theory of general anesthesia". Science 134 (3471): 15–21. Bibcode : 1961Sci...134...15P . doi : 10.1126/science.134.3471.15 . PMID 13733483 . Reprinted as Pauling, Linus; Kamb, Barclay, eds. (2001). Linus Pauling: Selected Scientific Papers 2 . River Edge, New Jersey: World Scientific. pp. 1328–1334. ISBN 981-02-2940-2 . ^ Henderson, W. (2000). Main group chemistry . Great Britain: Royal Society of Chemistry. p. 148. ISBN 0-85404-617-8 . ^ Ikeda, Tomoko; Mae, Shinji; Yamamuro, Osamu; Matsuo, Takasuke; Ikeda, Susumu; Ibberson, Richard M. (November 23, 2000). "Distortion of Host Lattice in Clathrate Hydrate as a Function of Guest Molecule and Temperature". Journal of Physical Chemistry A 104 (46): 10623–10630. doi : 10.1021/jp001313j . ^ Kleppe, Annette K.; Amboage, Mónica; Jephcoat, Andrew P. (2014). "New high-pressure van der Waals compound Kr(H 2 ) 4 discovered in the krypton-hydrogen binary system". Scientific Reports 4 . doi : 10.1038/srep04989 . ^ McKay, C. P.; Hand, K. P.; Doran, P. T.; Andersen, D. T.; Priscu, J. C. (2003). "Clathrate formation and the fate of noble and biologically useful gases in Lake Vostok, Antarctica". Geophysical Letters 30 (13): 35. Bibcode : 2003GeoRL..30m..35M . doi : 10.1029/2003GL017490 . ^ Barrer, R. M.; Stuart, W. I. (1957). "Non-Stoichiometric Clathrate of Water". Proceedings of the Royal Society of London 243 (1233): 172–189. Bibcode : 1957RSPSA.243..172B . doi : 10.1098/rspa.1957.0213 . ^ Frunzi, Michael; Cross, R. James; Saunders, Martin (2007). "Effect of Xenon on Fullerene Reactions". Journal of the American Chemical Society 129 (43): 13343–6. doi : 10.1021/ja075568n . PMID 17924634 . ^ Silfvast, William Thomas (2004). Laser Fundamentals . Cambridge University Press . ISBN 0-521-83345-0 . ^ Webster, John G. (1998). The Measurement, Instrumentation, and Sensors Handbook . Springer. ISBN 3-540-64830-5 . ^ McGhee, Charles; Taylor, Hugh R.; Gartry, David S.; Trokel, Stephen L. (1997). Excimer Lasers in Ophthalmology . Informa Health Care. ISBN 1-85317-253-7 . ^ Staff (2007). "Xenon Applications" . Praxair Technology . Retrieved 2007-10-04 . ^ Baltás, E.; Csoma, Z.; Bodai, L.; Ignácz, F.; Dobozy, A.; Kemény, L. (2003). "A xenon-iodine electric discharge bactericidal lamp". Technical Physics Letters 29 (10): 871–872. Bibcode : 2003TePhL..29..871S . doi : 10.1134/1.1623874 . ^ Skeldon, M.D.; Saager, R.; Okishev, A.; Seka, W. (1997). "Thermal distortions in laser-diode- and flash-lamp-pumped Nd:YLF laser rods" (PDF) . LLE Review 71 : 137–144. Archived from the original ( PDF ) on October 16, 2003 . Retrieved 2007-02-04 . ^ Anonymous. "The plasma behind the plasma TV screen" . Plasma TV Science . Retrieved 2007-10-14 . ^ Marin, Rick (March 21, 2001). "Plasma TV: That New Object Of Desire" . The New York Times . Retrieved 2009-04-03 . ^ Waymouth, John (1971). Electric Discharge Lamps . Cambridge, MA: MIT Press . ISBN 0-262-23048-8 . ^ Patel, C. K. N.; Bennett Jr., W. R.; Faust, W. L.; McFarlane, R. A. (August 1, 1962). "Infrared spectroscopy using stimulated emission techniques". Physical Review Letters 9 (3): 102–104. Bibcode : 1962PhRvL...9..102P . doi : 10.1103/PhysRevLett.9.102 . ^ Patel, C. K. N.; Faust, W. L.; McFarlane, R. A. (December 1, 1962). "High gain gaseous (Xe-He) optical masers". Applied Physics Letters 1 (4): 84–85. Bibcode : 1962ApPhL...1...84P . doi : 10.1063/1.1753707 . ^ Bennett, Jr., W. R. (1962). "Gaseous optical masers". Applied Optics Supplement 1 : 24–61. Bibcode : 1962ApOpt...1S..24B . doi : 10.1364/AO.1.000024 . ^ "Laser Output" . University of Waterloo . Retrieved 2007-10-07 . ^ Baltás, E.; Csoma, Z.; Bodai, L.; Ignácz, F.; Dobozy, A.; Kemény, L. (2006). "Treatment of atopic dermatitis with the xenon chloride excimer laser". Journal of the European Academy of Dermatology and Venereology 20 (6): 657–60. doi : 10.1111/j.1468-3083.2006.01495.x . PMID 16836491 . ^ Singh, Sanjay (May 15, 2005). "Xenon: A modern anaesthetic" . Indian Express Newspapers Limited. Archived from the original on 2007-08-13 . Retrieved 2007-10-10 . ^ Tonner, P. H. (2006). "Xenon: one small step for anaesthesia ... ? (editorial review)". Current Opinion in Anaesthesiology 19 (4): 382–4. doi : 10.1097/01.aco.0000236136.85356.13 . PMID 16829718 . ^ a b Banks, P; Franks, NP; Dickinson, R (2010). "Competitive inhibition at the glycine site of the N-methyl-D-aspartate receptor mediates xenon neuroprotection against hypoxia-ischemia". Anesthesiology 112 (3): 614–22. doi : 10.1097/ALN.0b013e3181cea398 . PMID 20124979 . ^ Ma, D; Wilhelm, S; Maze, M; Franks, NP (2002). "Neuroprotective and neurotoxic properties of the 'inert' gas, xenon". Br J Anaesth 89 (5): 739–46. doi : 10.1093/bja/89.5.739 . PMID 12393773 . ^ Nagata, A; Nakao Si, S; Nishizawa, N; Masuzawa, M; Inada, T; Murao, K; Miyamoto, E; Shingu, K (2001). "Xenon inhibits but N(2)O enhances ketamine-induced c-Fos expression in the rat posterior cingulate and retrosplenial cortices". Anesth Analg 92 (2): 362–8. doi : 10.1213/00000539-200102000-00016 . PMID 11159233 . ^ Sakamoto, S; Nakao, S; Masuzawa, M; Inada, T; Maze, M; Franks, NP; Shingu, K (2006). "The differential effects of nitrous oxide and xenon on extracellular dopamine levels in the rat nucleus accumbens: a microdialysis study". Anesth Analg 103 (6): 1459–63. doi : 10.1213/01.ane.0000247792.03959.f1 . PMID 17122223 . ^ Gruss, M; Bushell, TJ; Bright, DP; Lieb, WR; Mathie, A; Franks, NP (2004). "Two-pore-domain K+ channels are a novel target for the anesthetic gases xenon, nitrous oxide, and cyclopropane". Mol Pharmacol 65 (2): 443–52. doi : 10.1124/mol.65.2.443 . PMID 14742687 . ^ Yamakura, T; Harris, RA (2000). "Effects of gaseous anesthetics nitrous oxide and xenon on ligand-gated ion channels. Comparison with isoflurane and ethanol". Anesthesiology 93 (4): 1095–101. doi : 10.1097/00000542-200010000-00034 . PMID 11020766 . ^ Rashid, MH; Furue, H; Yoshimura, M; Ueda, H (2006). "Tonic inhibitory role of α4β2 subtype of nicotinic acetylcholine receptors on nociceptive transmission in the spinal cord in mice". Pain 125 (1–2): 125–35. doi : 10.1016/j.pain.2006.05.011 . PMID 16781069 . ^ Lopez, Maria M.; Kosk-Kosicka, Danuta (1995). "How Do Volatile Anesthetics Inhibit Ca 2+ -ATPases?". The Journal of Biological Chemistry 270 (47): 28239–28245. doi : 10.1074/jbc.270.47.28239 . ^ Suzuki, T; Koyama, H; Sugimoto, M; Uchida, I; Mashimo, T (2002). "The diverse actions of volatile and gaseous anesthetics on human-cloned 5-hydroxytryptamine 3 receptors expressed in Xenopus oocytes". Anesthesiology 96 (3): 699–704. doi : 10.1097/00000542-200203000-00028 . PMID 11873047 . ^ Nickalls, R. W. D; Mapleson, W.W. "Age‐related iso‐MAC charts for isoflurane, sevoflurane and desflurane in man" . British Journal of Anesthesiology . ^ Goto, T; Nakata Y; Morita S (2003). "Will xenon be a stranger or a friend?: the cost, benefit, and future of xenon anesthesia" . Anesthesiology 98 (1): 1–2. doi : 10.1097/00000542-200301000-00002 . PMID 12502969 . Retrieved 2010-09-15 . ^ "Xenon Attenuates Cerebral Damage after Ischemia in Pigs" . Anesthesiology 102 (5): 929–936. May 2005. doi : 10.1097/00000542-200505000-00011 . ^ Dingley, J; Tooley, J; Porter, H; Thoresen, M (2006). "Xenon Provides Short-Term Neuroprotection in Neonatal Rats When Administered After Hypoxia-Ischemia" . Stroke. 2006; 37: 501-506 37 (2): 501–6. doi : 10.1161/01.STR.0000198867.31134.ac . PMID 16373643 . ^ Weber, NC; Toma, O; Wolter, JI; Obal, D; Müllenheim, J; Preckel, B; Schlack, W (2005). "The noble gas xenon induces pharmacological preconditioning in the rat heart in vivo via induction of PKC-epsilon and p38 MAPK" . Br J Pharmacol 144 (1): 123–32. doi : 10.1038/sj.bjp.0706063 . PMC 1575984 . PMID 15644876 . ^ Bantel, C; Maze, M; Trapp, S (2009). "Neuronal preconditioning by inhalational anesthetics: evidence for the role of plasmalemmal adenosine triphosphate-sensitive potassium channels" . Anesthesiology 110 (5): 986–95. doi : 10.1097/ALN.0b013e31819dadc7 . PMC 2930813 . PMID 19352153 . ^ Bantel, C; Maze, M; Trapp, S (2010). "Noble gas xenon is a novel adenosine triphosphate-sensitive potassium channel opener" . Anesthesiology 112 (3): 623–30. doi : 10.1097/ALN.0b013e3181cf894a . PMC 2935677 . PMID 20179498 . ^ Staff (April 9, 2010). "First baby given xenon gas to prevent brain injury" . BBC News . Retrieved 2010-04-09 . ^ Newman, Sian. "Xenon gas used in a bid to reduce brain injury in newborns" . Swansea University . Retrieved 2011-10-19 . ^ "Breathe it in" . The Economist . 8 February 2014. ^ "WADA amends Section S.2.1 of 2014 Prohibited List" . 31 August 2014. ^ Van Der Wall, Ernst (1992). What's New in Cardiac Imaging?: SPECT, PET, and MRI . Springer. ISBN 0-7923-1615-0 . ^ Frank, John (1999). "Introduction to imaging: The chest" . Student BMJ 12 : 1–44 . Retrieved 2008-06-04 . ^ Chandak, Puneet K. (July 20, 1995). "Brain SPECT: Xenon-133" . Brigham RAD . Retrieved 2008-06-04 . ^ Albert, M. S.; Balamore, D. (1998). "Development of hyperpolarized noble gas MRI". Nuclear Instruments and Methods in Physics Research A 402 (2–3): 441–53. Bibcode : 1998NIMPA.402..441A . doi : 10.1016/S0168-9002(97)00888-7 . PMID 11543065 . ^ Irion, Robert (March 23, 1999). "Head Full of Xenon?" . Science News. Archived from the original on January 17, 2004 . Retrieved 2007-10-08 . ^ Wolber, J.; Rowland, I. J.; Leach, M. O.; Bifone, A. (1998). "Intravascular delivery of hyperpolarized 129Xenon for in vivo MRI". Applied Magnetic Resonance 15 (3–4): 343–352. doi : 10.1007/BF03162020 . ^ Driehuys, B.; Möller, H.E.; Cleveland, Z.I.; Pollaro, J.; Hedlund, L.W. (2009). "Pulmonary perfusion and xenon gas exchange in rats: MR imaging with intravenous injection of hyperpolarized 129Xe" . Radiology 252 (2): 386–93. doi : 10.1148/radiol.2522081550 . PMC 2753782 . PMID 19703880 . SSRN 2 . ^ Cleveland, Z.I.; Möller, H.E.; Hedlund, L.W.; Driehuys, B. (2009). "Continuously infusing hyperpolarized 129Xe into flowing aqueous solutions using hydrophobic gas exchange membranes" . The journal of physical chemistry 113 (37): 12489–99. doi : 10.1021/jp9049582 . PMC 2747043 . PMID 19702286 . ^ Luhmer, M.; Dejaegere, A.; Reisse, J. (1989). "Interpretation of the solvent effect on the screening constant of Xe-129". Magnetic Resonance in Chemistry 27 (10): 950–952. doi : 10.1002/mrc.1260271009 . ^ Rubin, Seth M.; Spence, Megan M.; Goodson, Boyd M.; Wemmer, David E.; Pines, Alexander (August 15, 2000). "Evidence of nonspecific surface interactions between laser-polarized xenon and myoglobin in solution" . Proceedings of the National Academy of Sciences USA 97 (17): 9472–5. Bibcode : 2000PNAS...97.9472R . doi : 10.1073/pnas.170278897 . PMC 16888 . PMID 10931956 . ^ Raftery, Daniel; MacNamara, Ernesto; Fisher, Gregory; Rice, Charles V.; Smith, Jay (1997). "Optical Pumping and Magic Angle Spinning: Sensitivity and Resolution Enhancement for Surface NMR Obtained with Laser-Polarized Xenon". Journal of the American Chemical Society 119 (37): 8746–8747. doi : 10.1021/ja972035d . ^ Gaede, H. C.; Song, Y. -Q.; Taylor, R. E.; Munson, E. J.; Reimer, J. A.; Pines, A. (1995). "High-field cross polarization NMR from laser-polarized xenon to surface nuclei". Applied Magnetic Resonance 8 (3–4): 373–384. doi : 10.1007/BF03162652 . ^ Galison, Peter Louis (1997). Image and Logic: A Material Culture of Microphysics . University of Chicago Press. p. 339. ISBN 0-226-27917-0 . ^ Fontaine, J.-P.; Pointurier, F.; Blanchard, X.; Taffary, T. (2004). "Atmospheric xenon radioactive isotope monitoring". Journal of Environmental Radioactivity 72 (1–2): 129–35. doi : 10.1016/S0265-931X(03)00194-2 . PMID 15162864 . ^ Garwin, Richard L.; von Hippel Frank N. (November 2006). "A Technical Analysis: Deconstructing North Korea's October 9 Nuclear Test" . Arms Control Today (Arms Control Association) 38 (9) . Retrieved 2009-03-26 . ^ Gallucci, G. (2009). "The MEG liquid xenon calorimeter". Journal of Physics: Conference Series 160 (1): 012011. Bibcode : 2009JPhCS.160a2011G . doi : 10.1088/1742-6596/160/1/012011 . ^ Zona, Kathleen (March 17, 2006). "Innovative Engines: Glenn Ion Propulsion Research Tames the Challenges of 21st century Space Travel" . NASA . Retrieved 2007-10-04 . ^ "Dawn Launch: Mission to Vesta and Ceres" (PDF) . NASA . Retrieved 2007-10-01 . ^ Brazzle, J. D.; Dokmeci, M. R.; Mastrangelo, C. H. (July 28 – August 1, 1975). Modeling and Characterization of Sacrificial Polysilicon Etching Using Vapor-Phase Xenon Difluoride . Proceedings 17th IEEE International Conference on Micro Electro Mechanical Systems (MEMS) (Maastricht, Netherlands: IEEE). pp. 737–740. ISBN 978-0-7803-8265-7 . ^ Staff (2007). "Neil Bartlett and the Reactive Noble Gases" . American Chemical Society . Retrieved June 5, 2012 . ^ Staff (December 21, 2004). "Protein Crystallography: Xenon and Krypton Derivatives for Phasing" . Daresbury Laboratory, PX. Archived from the original on 2005-03-16 . Retrieved 2007-10-01 . ^ Drenth, Jan; Mesters, Jeroen (2007). "The Solution of the Phase Problem by the Isomorphous Replacement Method". Principles of Protein X-Ray Crystallography (3rd ed.). New York: Springer . pp. 123–171. doi : 10.1007/0-387-33746-6_7 . ISBN 978-0-387-33334-2 . ^ a b Finkel, A. J.; Katz, J. J.; Miller, C. E. (April 1, 1968). "Metabolic and toxicological effects of water-soluble xenon compounds are studied" . NASA . Retrieved 2007-10-04 . ^ LeBlanc, Adrian D.; Johnson, Philip C. (1971). "The handling of xenon-133 in clinical studies". Physics in Medicine and Biology 16 (1): 105–9. Bibcode : 1971PMB....16..105L . doi : 10.1088/0031-9155/16/1/310 . PMID 5579743 . ^ 169.44 m/s in xenon (at 0°C and 107 KPa), compared to 344 m/s in air. See: Vacek, V.; Hallewell, G.; Lindsay, S. (2001). "Velocity of sound measurements in gaseous per-fluorocarbons and their mixtures". Fluid Phase Equilibria 185 (1–2): 305–314. doi : 10.1016/S0378-3812(01)00479-4 . ^ Spangler, Steve (2007). "Anti-Helium – Sulfur Hexafluoride" . Steve Spangler Science . Retrieved 2007-10-04 . ^ Yamaguchi, K.; Soejima, K.; Koda, E.; Sugiyama, N (2001). "Inhaling Gas With Different CT Densities Allows Detection of Abnormalities in the Lung Periphery of Patients With Smoking-Induced COPD". Chest Journal 51 (6): 1907–16. doi : 10.1378/chest.120.6.1907 . PMID 11742921 . ^ Staff (August 1, 2007). "Cryogenic and Oxygen Deficiency Hazard Safety" . Stanford Linear Accelerator Center. Archived from the original on June 9, 2007 . Retrieved 2007-10-10 . External links [ edit ] Find more about Xenon at Wikipedia's sister projects Definitions from Wiktionary Media from Commons Learning resources from Wikiversity Xenon at The Periodic Table of Videos (University of Nottingham) WebElements.com – Xenon USGS Periodic Table – Xenon EnvironmentalChemistry.com – Xenon Xenon as an anesthetic Sir William Ramsay's Nobel-Prize lecture (1904) v t e Periodic table (Large cells) 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 1 H He 2 Li Be B C N O F Ne 3 Na Mg Al Si P S Cl Ar 4 K Ca Sc Ti V Cr Mn Fe Co Ni Cu Zn Ga Ge As Se Br Kr 5 Rb Sr Y Zr Nb Mo Tc Ru Rh Pd Ag Cd In Sn Sb Te I Xe 6 Cs Ba La Ce Pr Nd Pm Sm Eu Gd Tb Dy Ho Er Tm Yb Lu Hf Ta W Re Os Ir Pt Au Hg Tl Pb Bi Po At Rn 7 Fr Ra Ac Th Pa U Np Pu Am Cm Bk Cf Es Fm Md No Lr Rf Db Sg Bh Hs Mt Ds Rg Cn Uut Fl Uup Lv Uus Uuo Alkali metal Alkaline earth metal Lan­thanide Actinide Transition metal Post-​transition metal Metalloid Polyatomic nonmetal Diatomic nonmetal Noble gas Unknown chemical properties v t e Xenon compounds Xenon(0) AuXe 4 (Sb 2 F 11 ) 2 Xenon(I) XePtF 6 XeRhF 6 XeF Xenon(II) XeF 2 XeFPtF 5 XeFPt 2 F 11 Xe 2 F 3 PtF 6 XeCl 2 XeBr 2 Organoxenon(II) compounds XeC 6 F 5 F XeC 6 F 5 C 2 F 3 XeC 6 F 5 CF 3 Xe(C 6 F 5 ) 2 XeC 6 F 5 C 6 H 2 F 3 XeC 6 F 5 CN Xe(CF 3 ) 2 Xenon(IV) XeO 2 XeF 4 XeOF 2 N(CH 3 ) 4 XeF 5 XeCl 4 Organoxenon(IV) compounds XeF 2 C 6 F 5 BF 4 Xenon(VI) XeO 3 XeF 6 XeOF 4 H 2 XeO 4 (NO) 2 XeF 8 CsXeF 7 RbXeF 7 Xenon(VIII) XeO 4 H 4 XeO 6 v t e General anesthetics ( N01A ) Inhalational Chloroethane (ethyl chloride) ‡ Chloroform ‡ Cyclopropane ‡ Desflurane Diethyl ether ‡ Enflurane Ethylene ‡ Fluroxene ‡ Halothane # Isoflurane Methoxyflurane Methoxypropane ‡ Nitrous oxide # Sevoflurane Trichloroethylene ‡ Vinyl ether ‡ Xenon Injection Barbiturates Hexobarbital Methohexital Narcobarbital Thiopental # Thiotetrabarbital Opioids Alfentanil Anileridine ‡ Fentanyl Phenoperidine Remifentanil Sufentanil Arylcyclohexylamines Esketamine Ketamine # Phencyclidine ‡ Tiletamine Others Alfadolone Alfaxalone Etomidate Fospropofol Hydroxydione GHB Metomidate Midazolam Propanidid ‡ Propofol # WHO-EM ‡ Withdrawn from market Clinical trials : † Phase III § Never to phase III v t e Cholinergics Receptor ligands mACh Agonists: 77-LH-28-1 AC-42 AC-260,584 Aceclidine Acetylcholine AF30 AF150(S) AF267B AFDX-384 Alvameline AQRA-741 Arecoline Bethanechol Butyrylcholine Carbachol CDD-0034 CDD-0078 CDD-0097 CDD-0098 CDD-0102 Cevimeline Choline cis-Dioxolane Ethoxysebacylcholine Itameline LY-593,039 L-689,660 LY-2,033,298 McNA343 Methacholine Milameline Muscarine NGX-267 Ocvimeline Oxotremorine PD-151,832 Pilocarpine RS86 Sabcomeline SDZ 210-086 Sebacylcholine Suberyldicholine Talsaclidine Tazomeline Thiopilocarpine Vedaclidine VU-0029767 VU-0090157 VU-0152099 VU-0152100 VU-0238429 WAY-132,983 Xanomeline YM-796 Antagonists: 3-Quinuclidinyl benzilate 4-DAMP Aclidinium bromide Anisodamine Anisodine Antihistamines (first-generation) (e.g., brompheniramine , chlorphenamine , cyproheptadine , dimenhydrinate , diphenhydramine , doxylamine , mepyramine (pyrilamine) , phenindamine , pheniramine , promethazine , tripelennamine , triprolidine ) Atropine Atropine methonitrate Atypical antipsychotics (e.g., clozapine , olanzapine , quetiapine , zotepine ) Benactyzine Benzatropine (benztropine) Benzilylcholine mustard Benzydamine BIBN 99 Biperiden Bornaprine CAR-226,086 CAR-301,060 CAR-302,196 CAR-302,282 CAR-302,368 CAR-302,537 CAR-302,668 CS-27349 Cyclobenzaprine Cyclopentolate Darifenacin DAU-5884 Dimethindene Dexetimide DIBD Dicyclomine (dicycloverine) Ditran EA-3167 EA-3443 EA-3580 EA-3834 Etanautine Etybenzatropine (ethybenztropine) Flavoxate Himbacine HL-031,120 Ipratropium bromide J-104,129 Hyoscyamine Mamba toxin 3 Mamba toxin 7 Mazaticol Mebeverine Methoctramine Metixene N-Ethyl-3-piperidyl benzilate N-Methyl-3-piperidyl benzilate Orphenadrine Otenzepad Oxybutynin PBID PD-102,807 PD-0298029 Phenglutarimide Phenyltoloxamine Pirenzepine Piroheptine Procyclidine Profenamine RU-47,213 SCH-57,790 SCH-72,788 SCH-217,443 Scopolamine (hyoscine) Solifenacin Telenzepine Tetracyclic antidepressants (e.g., amoxapine , maprotiline , mianserin , mirtazapine ) Tiotropium bromide Tolterodine Tricyclic antidepressants (e.g., amitriptyline , butriptyline , clomipramine , desipramine , dosulepin (dothiepin) , doxepin , imipramine , lofepramine , nortriptyline , protriptyline , trimipramine ) Trihexyphenidyl Tripitamine Tropatepine Tropicamide Typical antipsychotics (e.g., chlorpromazine , loxapine , thioridazine ) WIN-2299 Xanomeline Zamifenacin nACh Agonists: 5-HIAA A-84,543 A-366,833 A-582,941 A-867,744 ABT-202 ABT-418 ABT-560 ABT-894 Acetylcholine Altinicline Anabasine Anatoxin-a AR-R17779 Butinoline Butyrylcholine Carbachol Choline Cotinine Cytisine Decamethonium Desformylflustrabromine Dianicline Dimethylphenylpiperazinium Epibatidine Epiboxidine Ethanol Ethoxysebacylcholine EVP-4473 EVP-6124 Galantamine GTS-21 Ispronicline Ivermectin Levamisole Lobeline MEM-63,908 (RG-3487) Morantel Nicotine ( tobacco ) NS-1738 PHA-543,613 PHA-709,829 PNU-120,596 PNU-282,987 Pozanicline Rivanicline RJR-2429 Sazetidine A SB-206553 Sebacylcholine SIB-1508Y SIB-1553A SSR-180,711 Suberyldicholine Suxamethonium (succinylcholine) TC-1698 TC-1734 TC-1827 TC-2216 TC-5214 TC-5619 TC-6683 Tebanicline Tropisetron UB-165 Varenicline WAY-317,538 XY-4083 Antagonists: 18-MAC 18-MC α-Neurotoxins (e.g., α-bungarotoxin , α-cobratoxin , α-conotoxin , many others) ABT-126 Alcuronium Allopregnanolone Amantadine Anatruxonium AQW051 Atracurium Barbiturates (e.g., pentobarbital , sodium thiopental ) Bungarotoxins (e.g., α-bungarotoxin , κ-bungarotoxin ) Bupropion Chandonium Chlorisondamine Cisatracurium Coclaurine Coronaridine Cyclopropane Dacuronium Decamethonium Dehydronorketamine Desflurane Dextromethorphan Dextropropoxyphene Dextrorphan Diadonium DHβE Dihydrochandonium Dimethyltubocurarine (metocurine) Dipyrandium Dizocilpine (MK-801) Doxacurium Encenicline Enflurane Esketamine Fazadinium Gallamine Halothane Hexafluronium Hexamethonium (benzohexonium) Hydroxybupropion Hydroxynorketamine Ibogaine Isoflurane Ketamine Kynurenic acid Laudexium (laudolissin) Levacetylmethadol Levomethadone Malouetine ME-18-MC Mecamylamine Memantine Methadone Methorphan (racemethorphan) Methyllycaconitine Metocurine Mivacurium Morphanol (racemorphan) Neramexane Nitrous oxide Norketamine Pancuronium bromide Pempidine Pentamine Pentolinium Phencyclidine Pipecuronium Progesterone Promegestone Radafaxine Rapacuronium Reboxetine Rocuronium Sevoflurane Surugatoxin Thiocolchicoside Toxiferine Tramadol Trimetaphan camsilate (trimethaphan camsylate) Tropeinium Tubocurarine Vanoxerine Vecuronium Xenon Transporter ligands CHT Inhibitors: Hemicholinium-3 (hemicholine) Triethylcholine Enhancers: Coluracetam VAChT Inhibitors: Vesamicol Enzyme modulators ChAT Inhibitors: 1-(-Benzoylethyl)pyridinium 2-(α-Naphthoyl)ethyltrimethylammonium 3-Chloro-4-stillbazole 4-(1-Naphthylvinyl)pyridine Acetylseco hemicholinium-3 Acryloylcholine AF64A B115 BETA CM-54,903 N,N-Dimethylaminoethylacrylate N,N-Dimethylaminoethylchloroacetate AChE Inhibitors: Reversible: Carbamates: Aldicarb Bendiocarb Bufencarb Caffeine Carbaryl Carbendazim Carbetamide Carbofuran Chlorbufam Chloropropham Ethienocarb Ethiofencarb Fenobucarb Fenoxycarb Formetanate Furadan Ladostigil Methiocarb Methomyl Miotine Oxamyl Phenmedipham Pinmicarb Pirimicarb Propamocarb Propham Propoxur ; Stigmines: Distigmine bromide Eptastigmine Ganstigmine Neostigmine Phenserine Physostigmine Pyridostigmine bromide Quilostigmine Rivastigmine Terestigmine ; Others: Acotiamide Ambenonium Donepezil Caffeine Edrophonium Galantamine Huperzine A Ipidacrine Minaprine Tacrine Zanapezil Irreversible: Organophosphates: Acephate Azinphos-methyl Bensulide Cadusafos Chlorethoxyfos Chlorfenvinphos Chlorpyrifos Chlorpyrifos-methyl Coumaphos Cyclosarin Demeton Demeton-S-methyl Diazinon Dichlorvos Dicrotophos Diisopropyl fluorophosphate Diisopropylphosphate Dimethoate Dioxathion Disulfoton EA-3148 Echothiophate Ethion Ethoprop Fenamiphos Fenitrothion Fenthion Fosthiazate GV Isofluorophate Isoxathion Malaoxon Malathion Methamidophos Methidathion Metrifonate Mevinphos Monocrotophos Naled Novichok agent Omethoate Oxydemeton-methyl Paraoxon Parathion Parathion-methyl Phorate Phosalone Phosmet Phoxim Pirimiphos-methyl Sarin Soman Tabun Tebupirimfos Temefos Terbufos Tetrachlorvinphos Tribufos Trichlorfon VE VG VM VR VX ; Others: Demecarium Fasciculins (green mamba toxins) ( 1 , 2 , 3 , 4 ) Onchidal ( Onchidella binneyi ) Reactivators: Asoxime Obidoxime Pralidoxime BChE Inhibitors: Cymserine Many of the AChE inhibitors listed above Release modulators Inhibitors SNAP-25 inactivators: Botulinum toxin ( A , C , E ) VAMP inactivators: Botulinum toxin ( B , D , F , G ) Others: Bungarotoxins ( β-bungarotoxin , γ-bungarotoxin ) Enhancers LPHN agonists: α-Latrotoxin Others: Atracotoxin (e.g., robustoxin , versutoxin ) Crotoxin Others Precursors Choline ( lecithin ) Citicoline Cyprodenate Dimethylethanolamine Glycerophosphocholine Meclofenoxate (centrophenoxine) Phosphatidylcholine Phosphatidylethanolamine Phosphorylcholine Pirisudanol Cofactors Acetic acid Acetylcarnitine Acetyl-coA Vitamin B 5 v t e Glutamatergics Receptor ( ligands ) AMPA Agonists: Glutamate/active site agonists: 5-Fluorowillardiine Acromelic acid (acromelate) AMPA BOAA Domoic acid Glutamate Ibotenic acid Proline Quisqualic acid Willardiine ; Positive allosteric modulators: Aniracetam Cyclothiazide CX-516 CX-546 CX-614 Farampator (CX-691, Org 24448) CX-717 CX-1739 CX-1942 Diazoxide Hydrochlorothiazide (HCTZ) IDRA-21 LY-392,098 LY-404,187 LY-451,646 LY-503,430 Mibampator (LY-451,395) Org 26576 Oxiracetam PEPA PF-04958242 Piracetam Pramiracetam S-18986 Sunifiram Unifiram Antagonists: ACEA-1011 ATPO Becampanel Caroverine CNQX Dasolampanel DNQX Fanapanel (MPQX) GAMS GYKI-52466 Kynurenic acid Kynurenine Licostinel (ACEA-1021) NBQX PNQX Selurampanel Tezampanel Theanine Topiramate YM90K Zonampanel ; Negative allosteric modulators: Barbiturates (e.g., pentobarbital , sodium thiopental ) Cyclopropane Enflurane Ethanol Evans blue GYKI-53,655 Halothane Irampanel Isoflurane Perampanel Pregnenolone sulfate Talampanel NMDA Agonists: Glutamate/active site agonists: AMAA Aspartate Glutamate Homocysteic acid ( L -HCA) Homoquinolinic acid Ibotenic acid NMDA Proline Quinolinic acid Tetrazolylglycine Theanine ; Glycine site agonists: β-Fluoro- D -alanine ACBD ACC (ACPC) ACPD AK-51 CCG D -Alanine D -Cycloserine D -Serine DHPG Glycine HA-966 L-687,414 L -Alanine L -Serine Milacemide Neboglamine NRX-1074 Rapastinel (GLYX-13) Sarcosine ; Polyamine site agonists: Spermidine Spermine ; Other positive allosteric modulators: 24S-Hydroxycholesterol DHEA DHEA sulfate Pregnenolone sulfate Antagonists: Competitive antagonists: AP5 (APV) AP7 CGP-37849 CGP-39551 CGP-39653 CGP-40116 CGS-19755 CPP LY-233,053 LY-235,959 LY-274,614 MDL-100,453 Midafotel (d-CPPene) NPC-12,626 NPC-17,742 PBPD PEAQX Perzinfotel PPDA SDZ-220581 Selfotel ; Noncompetitive antagonists: ARR-15,896 Caroverine Dexanabinol FPL-12495 FR-115,427 Hodgkinsine Magnesium MDL-27,266 NPS-1506 Psychotridine Zinc ; Uncompetitive pore blockers: 2-MDP 3-HO-PCP 3-MeO-PCE 3-MeO-PCMo 3-MeO-PCP 4-MeO-PCP 8A-PDHQ 18-MC α-Endopsychosin Alaproclate Amantadine Aptiganel Arketamine ARL-12,495 ARL-15,896-AR ARL-16,247 Budipine Conaridine Delucemine Dexoxadrol Dextrallorphan Dieticyclidine Diphenidine Dizocilpine Ephenidine Esketamine Etoxadrol Eticyclidine Fluorolintane Gacyclidine Ibogaine Ibogamine Indantadol Ketamine Ketobemidone Lanicemine Loperamide Memantine Methadone ( Levomethadone ) Methorphan ( Dextromethorphan Levomethorphan ) Methoxetamine Methoxphenidine Milnacipran Morphanol ( Dextrorphan Levorphanol ) NEFA Neramexane Nitromemantine Nitrous oxide Noribogaine Norketamine Orphenadrine PCPr Pethidine (meperidine) Phencyclamine Phencyclidine Propoxyphene Remacemide Rhynchophylline Rimantadine Rolicyclidine Sabeluzole Tabernanthine Tenocyclidine Tiletamine Tramadol Xenon ; Glycine site antagonists: 4-Cl-KYN (AV-101) 5,7-DCKA 7-CKA ACC ACEA-1011 ACEA-1328 AV-101 Carisoprodol CGP-39653 CNQX DNQX Felbamate Gavestinel GV-196,771 Kynurenic acid Kynurenine L-689,560 L-701,324 Licostinel (ACEA-1021) LU-73,068 MDL-105,519 Meprobamate MRZ 2/576 PNQX ZD-9379 ; NR2B subunit antagonists: Besonprodil CERC-301 (MK-0657) CO-101,244 (PD-174,494) Eliprodil Haloperidol Ifenprodil Isoxsuprine Nylidrin Ro8-4304 Ro25-6981 Traxoprodil ; Polyamine site antagonists: Arcaine Co 101676 Diaminopropane Diethylenetriamine Huperzine A Putrescine Ro 25-6981 ; Unclassified/unsorted antagonists: Bumetanide Chloroform Cyclopropane D -αAA Diethyl ether Enflurane Ethanol Flufenamic acid Flupirtine Furosemide Halothane Isoflurane Metaphit Methoxyflurane Niflumic acid Piretanide Toluene Transcrocetin ( saffron ) Trichloroethane Trichloroethanol Trichloroethylene Xylene Kainate Agonists: Glutamate/active site agonists: 5-Bromowillardiine 5-Iodowillardiine Acromelic acid (acromelate) AMPA ATPA Domoic acid Glutamate Ibotenic acid Kainic acid LY-339,434 Proline Quisqualic acid SYM-2081 ; Positive allosteric modulators: Cyclothiazide Diazoxide Enflurane Halothane Isoflurane Antagonists: ACEA-1011 CNQX Dasolampanel DNQX GAMS Kynurenic acid Licostinel (ACEA-1021) LY-382,884 NBQX NS102 Selurampanel Tezampanel Theanine Topiramate UBP-302 ; Negative allosteric modulators: Barbiturates (e.g., pentobarbital , sodium thiopental ) Enflurane Ethanol Evans blue NS-3763 Pregnenolone sulfate mGlu 1 Agonists: ACPD DHPG Glutamate Ibotenic acid Quisqualic acid Ro01-6128 Ro67-4853 Ro67-7476 VU-71 Antagonists: BAY 36-7620 CPCCOEt Cyclothiazide LY-367,385 LY-456,236 MCPG NPS-2390 mGlu 2 Agonists: BINA CBiPES DCG-IV Eglumegad Glutamate Ibotenic acid LY-379,268 LY-404,039 (pomaglumetad) LY-487,379 LY-566,332 MGS-0028 Pomaglumetad methionil (LY-2140023) Talaglumetad ; Positive allosteric modulators: JNJ-40411813 (ADX-71149) Antagonists: APICA CECXG EGLU HYDIA LY-307,452 LY-341,495 MCPG MGS-0039 PCCG-4 ; Negative allosteric modulators: Decoglurant RO4491533 mGlu 3 Agonists: CBiPES DCG-IV Eglumegad Glutamate Ibotenic acid LY-379,268 LY-404,039 (pomaglumetad) LY-487,379 MGS-0028 Pomaglumetad methionil (LY-2140023) Talaglumetad Antagonists: APICA CECXG EGLU HYDIA LY-307,452 LY-341,495 MCPG MGS-0039 ; Negative allosteric modulators: Decoglurant RO4491533 mGlu 4 Agonists: Glutamate L -AP4 PHCCC VU-001,171 VU-0155,041 ; Positive allosteric modulators: MPEP Antagonists: CPPG MAP4 MPPG MSOP MTPG UBP-1112 mGlu 5 Agonists: ACPD ADX-47273 CDPPB CHPG DFB DHPG Glutamate Ibotenic acid Quisqualic acid VU-1545 Antagonists: CTEP DMeOB LY-344,545 Mavoglurant MCPG NPS-2390 Remeglurant SIB-1757 SIB-1893 ; Negative allosteric modulators: Basimglurant Dipraglurant Fenobam GRN-529 MPEP MTEP Raseglurant mGlu 6 Agonists: Glutamate L -AP4 Antagonists: CPPG MAP4 MPPG MSOP MTPG UBP-1112 mGlu 7 Agonists: AMN082 Glutamate L -AP4 Antagonists: CPPG MAP4 MMPIP MPPG MSOP MTPG UBP-1112 mGlu 8 Agonists: DCPG Glutamate L -AP4 Antagonists: CPPG MAP4 MPPG MSOP MTPG UBP-1112 Transporter ( blockers ) EAATs Amphetamine Aspartic acid (aspartate) cis -ACBD DHKA Glutamic acid (glutamate) HIP-A HIP-B Kainic acid L -(-)- threo -3-Hydroxyaspartic acid L -αAA L -CCG-III ((2S,3S,4R)-CCG) L -Serine-O-sulphate (SOS) L - trans -2,4-PDC MPDC SYM-2081 TBOA TFB-TBOA Theanine threo -3-Methylglutamic acid UCPH-101 WAY-213,613 vGluTs 4-Methylene- L -glutamate 6-(4'-Phenylstyryl)-QDC 6-Biphenyl-4-yl-QDC 7-CKA Acid red 114 Amido black 10B (naphthol blue black) Bafilomycin A1 Benzopurpurin 4B Bumetamide Chicago sky blue 6B Aspartic acid (aspartate) DIDS Direct blue 71 Erythro-4-methyl- L -glutamic acid Evans blue Furosemide Glutamic acid (glutamate) Kynurenic acid Nigericin NPPB (N144) Ponceau SS Reactive blue 2 Rose bengal SITS trans -ACDP Trypan blue Valinomycin Xanthurenic acid Enzyme ( inhibitors ) GAH BPTES CB-839 DON AST 2-Amino-3-butenoic acid AAOA AMB β- DL -Methylene-aspartate Hydrazinosuccinate ALT β-Chloro- L -alanine L -Cycloserine Propargylglycine GDH AAOA Bithionol Chloroquine EGCG GTP GW5074 Hexachlorophene Hydroxylamine Palmitoyl-CoA Pyridoxal phosphate GS 2-Aminoadipic acid JFD01307SC Methionine sulfoximine Phosphinothricin (glufosinate) GAD 3-Mercaptopropionic acid AAOA L -Allylglycine Semicarbazide Others Precursors: GHB L -Glutamine Cofactors: α-Ketoglutaric acid Iron Sulfur Vitamin B 2 Vitamin B 3 Others: Acamprosate Cysteine Cytidine Cytisine Glutathione Glutathione disulfide Minocycline N-Acetylcysteine Riluzole S-Nitrosoglutathione Tianeptine See also: GABAergics • GHBergics • Glycinergics v t e Glycinergics Receptor ( ligands ) GlyR Agonists: β-Alanine β-ABA (BABA) β-AIBA Caesium D -Alanine D -Serine GABA Glycine Hypotaurine Ivermectin L -Alanine L -Proline L -Serine L -Threonine MDL-27531 Milacemide Picolinic acid Propofol Quisqualamine Sarcosine Taurine PAMs: Alcohols (e.g., brometone , chlorobutanol (chloretone) , ethanol , tert -butanol (2M2P) , tribromoethanol , trichloroethanol , trifluoroethanol ) Alkylbenzene sulfonate Anandamide Barbiturates (e.g., pentobarbital , sodium thiopental ) Chlormethiazole D12-116 Dihydropyridines (e.g., nicardipine ) Etomidate Ginseng constituents (e.g., ginsenosides (e.g., ginsenoside-Rf )) Glutamic acid (glutamate) Ivermectin Ketamine Neuroactive steroids (e.g., alfaxolone , pregnenolone (eltanolone) , pregnenolone acetate , minaxolone , Org 20599 ) Nitrous oxide Penicillin G Propofol Tamoxifen Tetrahydrocannabinol Triclofos Tropeines (e.g., atropine , bemesetron , cocaine , LY-278584 , tropisetron , zatosetron ) Volatiles / gases (e.g., chloral hydrate , chloroform , desflurane , diethyl ether (ether) , enflurane , halothane , isoflurane , methoxyflurane , sevoflurane , toluene , trichloroethane (methyl chloroform) , trichloroethylene ) Xenon Zinc Antagonists: 2-Aminostrychnine 2-Nitrostrychnine 4-Phenyl-4-formyl-N-methylpiperidine αEMBTL Bicuculline Brucine Cacotheline Caffeine Colchicine Colubrine Cyanotriphenylborate Dendrobine Diaboline Endocannabinoids (e.g., 2-AG , anandamide (AEA) ) Gaboxadol (THIP) Gelsemine iso-THAZ Isobutyric acid Isonipecotic acid Isostrychnine Laudanosine N-Methylbicuculline N-Methylstrychnine N,N-Dimethylmuscimol Nipecotic acid Pitrazepin Pseudostrychnine Quinolines (e.g., 4-hydroxyquinoline , 4-hydroxyquinoline-3-carboxylic acid , 5,7-CIQA , 7-CIQ , 7-TFQ , 7-TFQA ) RU-5135 Sinomenine Strychnine Thiocolchicoside Tutin NAMs: Amiloride Benzodiazepines (e.g., bromazepam , clonazepam , diazepam , flunitrazepam , flurazepam ) Corymine Cyanotriphenylborate Daidzein Dihydropyridines (e.g., nicardipine , nifedipine , nitrendipine ) Furosemide Genistein Ginkgo constituents (e.g., bilobalide , ginkgolides (e.g., ginkgolide A , ginkgolide B , ginkgolide C , ginkgolide J , ginkgolide M )) Imipramine NBQX Neuroactive steroids (e.g., 3α-androsterone sulfate , 3β-androsterone sulfate , deoxycorticosterone , DHEA sulfate , pregnenolone sulfate , progesterone ) Opioids (e.g., codeine , dextromethorphan , dextrorphan , levomethadone , levorphanol , morphine , oripavine , pethidine , thebaine ) Picrotoxin (i.e., picrotin and picrotoxinin ) PMBA Riluzole Tropeines (e.g., bemesetron , LY-278584 , tropisetron , zatosetron ) Verapamil Zinc Transporter ( blockers ) GlyT1 ACPPB ALX-1393 ALX-5407 (NFPS) AMG-747 ASP2535 Bitopertin (RG1678/RO4917838) CP-802079 Ethanol Glycyldodecylamide GSK1018921 LY-2365109 Org 24598 Org 25935 (SCH-900435) PF-02545920 PF-03463275 PF-04958242 Sarcosine SSR-103,800 SSR-504,734 GlyT2 Amoxapine Ethanol NAGly Org 25543 Others Precursors: 3-PG GHB L -Serine L -Theonine Cofactors: Vitamin B 6 See also: GABAergics • GHBergics • Glutamatergics v t e Serotonergics 5-HT 1 receptor ligands 5-HT 1A Agonists: 8-OH-DPAT Adatanserin Amphetamine Antidepressants (e.g., etoperidone , nefazodone , trazodone , vilazodone , vortioxetine ) Atypical antipsychotics (e.g., aripiprazole , asenapine , clozapine , lurasidone , quetiapine , ziprasidone ) Azapirones (e.g., buspirone , eptapirone , gepirone , perospirone , tandospirone ) Bay R 1531 Befiradol BMY-14802 Cannabidiol Dimemebfe Dopamine Ebalzotan Eltoprazine Ergolines (e.g., bromocriptine , cabergoline , dihydroergotamine , ergotamine , lisuride , LSD , methylergometrine (methylergonovine) , methysergide , pergolide ) F-11461 F-12826 F-13714 F-14679 F-15063 F-15599 Flesinoxan Flibanserin Lesopitron LY-293284 LY-301317 mCPP MKC-242 Naluzotan NBUMP Osemozotan Oxaflozane Pardoprunox Piclozotan Rauwolscine Repinotan Roxindole RU-24969 S-14506 S-14671 S-15535 Sarizotan Serotonin (5-HT) SSR-181507 Sunepitron Tryptamines (e.g., 5-CT , 5-MeO-DMT , 5-MT , bufotenin , DMT , indorenate , N-Me-5-HT , psilocin , psilocybin ) TGBA01AD U-92016A Urapidil Vilazodone Xaliproden Yohimbine Antagonists: Atypical antipsychotics (e.g., iloperidone , risperidone , sertindole ) AV965 Beta blockers (e.g., alprenolol , cyanopindolol , iodocyanopindolol , oxprenolol , pindobind , pindolol , propranolol , tertatolol ) BMY-7378 CSP-2503 Dotarizine Ergolines (e.g., metergoline ) Flopropione GR-46611 Isamoltane Lecozotan Mefway Metitepine (methiothepin) MIN-117 (WF-516) MPPF NAN-190 Robalzotan S-15535 SB-649915 SDZ 216-525 Spiperone Spiramide Spiroxatrine UH-301 WAY-100135 WAY-100635 Xylamidine Unknown/unsorted: Ergolines (e.g., ergometrine (ergonovine) ) 5-HT 1B Agonists: CGS-12066A CP-93129 CP-94253 CP-122,288 CP-135807 Eltoprazine Ergolines (e.g., bromocriptine , dihydroergotamine , ergotamine , methylergometrine (methylergonovine) , methysergide , pergolide ) mCPP RU-24969 Serotonin (5-HT) Triptans (e.g., avitriptan , donitriptan , eletriptan , sumatriptan , zolmitriptan ) TFMPP Tryptamines (e.g., 5-BT , 5-CT , 5-MT , DMT ) Vortioxetine Antagonists: AR-A000002 Elzasonan Ergolines (e.g., metergoline ) GR-127935 Isamoltane LY-393558 Metitepine (methiothepin) SB-216641 SB-224289 SB-236057 Yohimbine Unknown/unsorted: Ergolines (e.g., cabergoline , ergometrine (ergonovine) , lisuride ) 5-HT 1D Agonists: CP-122,288 CP-135807 CP-286601 Ergolines (e.g., bromocriptine , cabergoline , dihydroergotamine , ergotamine , LSD , methysergide ) GR-46611 L-694247 L-772405 mCPP PNU-109291 PNU-142633 Serotonin (5-HT) TGBA01AD Triptans (e.g., almotriptan , avitriptan , donitriptan , eletriptan , frovatriptan , naratriptan , rizatriptan , sumatriptan , zolmitriptan ) Tryptamines (e.g., 5-BT , 5-CT , 5-Et-DMT , 5-MT , 5-(nonyloxy)tryptamine , DMT ) Antagonists: Alniditan BRL-15572 Elzasonan Ergolines (e.g., metergoline ) GR-127935 Ketanserin LY-310762 LY-367642 LY-393558 LY-456219 LY-456220 Metitepine (methiothepin) Mianserin Ritanserin Yohimbine Ziprasidone Unknown/unsorted: Ergolines (e.g., lisuride , lysergol , pergolide ) 5-HT 1E Agonists: BRL-54443 Ergolines (e.g., methysergide ) Serotonin (5-HT) Triptans (e.g., eletriptan ) Tryptamines (e.g., tryptamine ) Antagonists: Metitepine (methiothepin) Unknown/unsorted: Ergolines (e.g., ergometrine (ergonovine) , lysergol , methylergometrine (methylergonovine) 5-HT 1F Agonists: BRL-54443 CP-122,288 Ergolines (e.g., bromocriptine , lysergol , methylergometrine (methylergonovine) methysergide ) Lasmiditan LY-334370 Serotonin (5-HT) Triptans (e.g., eletriptan , naratriptan , sumatriptan ) Tryptamines (e.g., 5-MT ) Antagonists: Mianserin Metitepine (methiothepin) 5-HT 2 receptor ligands 5-HT 2A Agonists: 25H/NB series (e.g., 25I-NBF , 25I-NBMD , 25I-NBOH , 25I-NBOMe , 25B-NBOMe , 25C-NBOMe , 25TFM-NBOMe , 2CBCB-NBOMe , 25CN-NBOH , 2CBFly-NBOMe ) 2Cs (e.g., 2C-B , 2C-E , 2C-I , 2C-T-2 , 2C-T-7 , 2C-T-21 ) 2C-B-FLY 2CB-Ind 5-Methoxytryptamines ( 5-MeO-DET , 5-MeO-DiPT , 5-MeO-DMT , 5-MeO-DPT , 5-MT ) α-Alkyltryptamines (e.g., 5-Cl-αMT , 5-Fl-αMT , 5-MeO-αET , 5-MeO-αMT , α-Me-5-HT , αET , αMT ) AL-34662 AL-37350A Bromo-DragonFLY Dimemebfe DMBMPP DOx (e.g., DOB , DOC , DOI , DOM ) Efavirenz Ergolines (e.g., 1P-LSD , ALD-52 , bromocriptine , cabergoline , ergine (LSA) , ergotamine , lisuride , LA-SS-Az , LSB , LSD , LSD-Pip , LSH , LSP , methylergometrine (methylergonovine) , pergolide ) Jimscaline Lorcaserin MDxx (e.g., MDA , MDMA , MDOH , MMDA ) O-4310 Oxaflozane PHA-57378 PNU-22394 PNU-181731 RH-34 Phenethylamines (e.g., lophophine , mescaline ) Piperazines (e.g., BZP , mCPP , quipazine , TFMPP ) Serotonin (5-HT) TCB-2 TFMFly Tryptamines (e.g., 5-BT , 5-CT , bufotenin , DET , DiPT , DMT , DPT , psilocin , psilocybin , tryptamine ) Antagonists: 5-I-R91150 5-MeO-NBpBrT AC-90179 Adatanserin Altanserin AMDA APD-215 Atypical antipsychotics (e.g., amperozide , aripiprazole , asenapine , blonanserin , carpipramine , clocapramine , clorotepine , clozapine , fluperlapine , gevotroline , iloperidone , melperone , mosapramine , olanzapine , paliperidone , quetiapine , risperidone , sertindole , zicronapine , ziprasidone , zotepine ) Cinanserin CSP-2503 Cyproheptadine Deramciclane Dotarizine Eplivanserin Ergolines (e.g., amesergide , LY-53857 , LY-215840 , mesulergine , metergoline , methysergide , sergolexole ) Etoperidone Fananserin Flibanserin Glemanserin Irindalone Ketanserin KML-010 Lubazodone LY-393558 Medifoxamine Mepiprazole Metitepine (methiothepin) MIN-101 Nantenine Nefazodone Phenoxybenzamine Pimavanserin Pirenperone Pizotifen Pruvanserin Rauwolscine Ritanserin S-14671 Sarpogrelate Setoperone Spiperone Spiramide SR-46349B TGBA01AD Teniloxazine Temanogrel Tetracyclic antidepressants (e.g., amoxapine , aptazapine , esmirtazapine , maprotiline , mianserin , mirtazapine ) Trazodone Tricyclic antidepressants (e.g., amitriptyline ) Typical antipsychotics (e.g., chlorpromazine , fluphenazine , haloperidol , loxapine , perphenazine , pimozide , pipamperone , prochlorperazine , thioridazine , thiothixene , trifluoperazine ) Volinanserin Xylamidine Yohimbine Unknown/unsorted: Ergolines (e.g., dihydroergotamine , ergometrine (ergonovine) , nicergoline ) MIN-117 (WF-516) 5-HT 2B Agonists: 4-Methylaminorex Aminorex Amphetamines (eg., chlorphentermine , cloforex , dexfenfluramine , fenfluramine , levofenfluramine , norfenfluramine ) BW-723C86 DOx (e.g., DOB , DOC , DOI , DOM ) Ergolines (e.g., cabergoline , dihydroergocryptine , dihydroergotamine , ergotamine , methylergometrine (methylergonovine) , methysergide , pergolide ) MDxx (e.g., MDA , MDMA , MDOH , MMDA ) Piperazines (e.g., mCPP ) PNU-22394 Ro60-0175 Serotonin (5-HT) Tryptamines (e.g., 5-BT , 5-CT , 5-MT , α-Me-5-HT , bufotenin , DET , DiPT , DMT , DPT , psilocin , psilocybin , tryptamine ) Antagonists: Agomelatine Asenapine Cyproheptadine EGIS-7625 Ergolines (e.g., amesergide , bromocriptine , lisuride , LY-53857 , LY-272015 , mesulergine ) Ketanserin LY-393558 Metadoxine Metitepine (methiothepin) Pirenperone Propranolol PRX-08066 Rauwolscine Ritanserin RS-127445 Sarpogrelate SB-200646 SB-204741 SB-206553 SB-215505 SB-221284 SB-228357 SDZ SER-082 Tegaserod Tetracyclic antidepressants (e.g., amoxapine , mianserin ) TIK-301 Yohimbine Unknown/unsorted: Ergolines (e.g., ergometrine (ergonovine) ) 5-HT 2C Agonists: 2Cs (e.g., 2C-B , 2C-E , 2C-I , 2C-T-2 , 2C-T-7 , 2C-T-21 ) 5-Methoxytryptamines ( 5-MeO-DET , 5-MeO-DiPT , 5-MeO-DMT , 5-MeO-DPT , 5-MT ) α-Alkyltryptamines (e.g., 5-Cl-αMT , 5-Fl-αMT , 5-MeO-αET , 5-MeO-αMT , α-Me-5-HT , αET , αMT ) A-372159 AL-38022A Alstonine CP-809101 Dimemebfe DOx (e.g., DOB , DOC , DOI , DOM ) Ergolines (e.g., ALD-52 , cabergoline , dihydroergotamine , ergine (LSA) , ergotamine , lisuride , LA-SS-Az , LSB , LSD , LSD-Pip , LSH , LSP , pergolide ) Lorcaserin MDxx (e.g., MDA , MDMA , MDOH , MMDA ) MK-212 Org 12962 Org 37684 Oxaflozane PHA-57378 Phenethylamines (e.g., lophophine , mescaline ) Piperazines (e.g., aripiprazole , BZP , mCPP , quipazine , TFMPP ) PNU-22394 PNU-181731 Ro60-0175 Ro60-0213 Serotonin (5-HT) Tryptamines (e.g., 5-BT , 5-CT , bufotenin , DET , DiPT , DMT , DPT , psilocin , psilocybin , tryptamine ) Vabicaserin WAY-629 WAY-161503 YM-348 Antagonists: Adatanserin Agomelatine Atypical antipsychotics (e.g., asenapine , clorotepine , clozapine , fluperlapine , iloperidone , melperone , olanzapine , paliperidone , quetiapine , risperidone , sertindole , ziprasidone , zotepine ) Captodiame CEPC Cinanserin Cyproheptadine Deramciclane Dotarizine Eltoprazine Ergolines (e.g., amesergide , bromocriptine , LY-53857 , LY-215840 , mesulergine , metergoline , methysergide , sergolexole ) Etoperidone Fluoxetine FR-260010 Irindalone Ketanserin Ketotifen Latrepirdine (dimebolin) Medifoxamine Metitepine (methiothepin) Nefazodone Pirenperone Pizotifen Propranolol Ritanserin RS-102221 S-14671 SB-200646 SB-206553 SB-221284 SB-228357 SB-242084 SB-243213 SDZ SER-082 Tedatioxetine Tetracyclic antidepressants (e.g., amoxapine , aptazapine , esmirtazapine , maprotiline , mianserin , mirtazapine ) TIK-301 Trazodone Tricyclic antidepressants (e.g., amitriptyline , nortriptyline ) Typical antipsychotics (e.g., chlorpromazine , loxapine , pimozide , pipamperone , thioridazine ) Xylamidine Unknown/unsorted: Efavirenz Ergolines (e.g., ergometrine (ergonovine) , methylergometrine (methylergonovine) ) 5-HT 3 5-HT 4 5-HT 5 5-HT 6 5-HT 7 ligands 5-HT 3 Agonists: Alcohols (e.g., butanol , ethanol , trichloroethanol ) m-CPBG Phenylbiguanide Piperazines (e.g., BZP , mCPP , quipazine ) RS-56812 Serotonin (5-HT) SR-57227 SR-57227A Tryptamines (e.g., 2-Me-5-HT , 5-CT , bufotenidine (5-HTQ) ) Volatiles/gases (e.g., halothane , isoflurane , toluene , trichloroethane ) YM-31636 Antagonists: Alosetron AS-8112 Atypical antipsychotics (e.g., clozapine , olanzapine , quetiapine ) Azasetron Batanopride Bemesetron (MDL-72222) Cilansetron CSP-2503 Dazopride Dolasetron Galanolactone Granisetron ICS-205930 Lerisetron Memantine Ondansetron Palonosetron Ramosetron Renzapride Ricasetron Tedatioxetine Tetracyclic antidepressants (e.g., amoxapine , mianserin , mirtazapine ) Thujone Tropanserin Tropisetron Typical antipsychotics (e.g., loxapine ) Volatiles/gases (e.g., nitrous oxide , sevoflurane , xenon ) Vortioxetine Zacopride Zatosetron Unknown/unsorted: LY-53857 Piperazines (e.g., naphthylpiperazine ) 5-HT 4 Agonists: 5-MT BIMU8 Cinitapride Cisapride CJ-033466 Dazopride Metoclopramide Mosapride Prucalopride PRX-03140 Renzapride RS-67333 RS-67506 Serotonin (5-HT) SL65.0155 Tegaserod Velusetrag Zacopride Antagonists: GR-113808 GR-125487 L-Lysine Piboserod RS-39604 RS-67532 SB-203186 SB-204070 5-HT 5A Agonists: Ergolines (e.g., 2-Br-LSD (BOL-148) , ergotamine , LSD ) Serotonin (5-HT) Tryptamines (e.g., 5-CT ) Valerenic Acid Antagonists: Asenapine Latrepirdine (dimebolin) Metitepine (methiothepin) Ritanserin SB-699551 Unknown/unsorted: Ergolines (e.g., metergoline , methysergide ) Piperazines (e.g., naphthylpiperazine ) 5-HT 6 Agonists: Ergolines (e.g., dihydroergocryptine , dihydroergotamine , ergotamine , lisuride , LSD , mesulergine , metergoline , methysergide ) Serotonin (5-HT) Tryptamines (e.g., 2-Me-5-HT , 5-BT , 5-CT , 5-MT , Bufotenin , E-6801 , E-6837 , EMD-386088 , EMDT , LY-586713 , N-Me-5-HT , tryptamine ) WAY-181187 WAY-208466 Antagonists: ABT-354 Atypical antipsychotics (e.g., aripiprazole , asenapine , clorotepine , clozapine , fluperlapine , iloperidone , olanzapine , tiospirone ) AVN-101 AVN-211 AVN-322 AVN-397 BGC20-760 BVT-5182 BVT-74316 Cerlapirdine EGIS-12233 GW-742457 Idalopirdine Ketanserin Latrepirdine (dimebolin) Metitepine (methiothepin) MS-245 PRX-07034 Ritanserin Ro04-6790 Ro 63-0563 SB-258585 SB-271046 SB-357134 SB-399885 SB-742457 Tetracyclic antidepressants (e.g., amoxapine , mianserin ) Tricyclic antidepressants (e.g., amitriptyline , clomipramine , doxepin , nortriptyline ) Typical antipsychotics (e.g., chlorpromazine , loxapine ) Unknown/unsorted: Ergolines (e.g., 2-Br-LSD (BOL-148) , bromocriptine , lergotrile , pergolide ) Piperazines (e.g., naphthylpiperazine ) 5-HT 7 Agonists: 8-OH-DPAT AS-19 Bifeprunox E-55888 Ergolines (e.g., LSD ) LP-12 LP-44 RU-24969 Sarizotan Serotonin (5-HT) Triptans (e.g., frovatriptan ) Tryptamines (e.g., 5-CT , 5-MT , bufotenin , N-Me-5-HT ) Antagonists: Atypical antipsychotics (e.g., amisulpride , aripiprazole , asenapine , clorotepine , clozapine , fluperlapine , olanzapine , risperidone , sertindole , tiospirone , ziprasidone , zotepine ) Butaclamol DR-4485 EGIS-12233 Ergolines (e.g., 2-Br-LSD (BOL-148) , amesergide , bromocriptine , cabergoline , dihydroergotamine , ergotamine , LY-53857 , LY-215840 , mesulergine , metergoline , methysergide , sergolexole ) Ketanserin LY-215840 Metitepine (methiothepin) Ritanserin SB-258719 SB-258741 SB-269970 SB-656104 SB-656104A SB-691673 SLV-313 SLV-314 Spiperone SSR-181507 Tetracyclic antidepressants (e.g., amoxapine , maprotiline , mianserin , mirtazapine ) Tricyclic antidepressants (e.g., amitriptyline , clomipramine , imipramine ) Typical antipsychotics (e.g., acetophenazine , chlorpromazine , chlorprothixene , fluphenazine , loxapine , pimozide ) Vortioxetine Unknown/unsorted: Ergolines (e.g., lisuride , pergolide ) Piperazines (e.g., naphthylpiperazine ) Reuptake inhibitors SERT Selective serotonin reuptake inhibitors (SSRIs): Alaproclate Cericlamine Citalopram Dapoxetine Desmethylcitalopram Escitalopram Femoxetine Fluoxetine Fluvoxamine Indalpine Ifoxetine Omiloxetine Panuramine Paroxetine Pirandamine RTI-353 Seproxetine Sertraline Vilazodone Zimelidine Serotonin-norepinephrine reuptake inhibitors (SNRIs): Bicifadine BTS-54505 Desvenlafaxine Duloxetine Eclanamine Levomilnacipran McN-5652 Milnacipran N-Methyl-PPPA PPPA Sibutramine Venlafaxine WY-45233 Serotonin-norepinephrine-dopamine reuptake inhibitors (SNDRIs): (S)-Duloxetine 3,3-Diphenylcyclobutanamine Amifitadine Ansofaxine Bicifadine Brasofensine Centanafadine Cocaine Dasotraline Desmethylsertraline Diclofensine DOV-102677 DOV-216303 EXP-561 Fezolamine HDMP-28 Indatraline JNJ-7925476 JZ-IV-10 Liafensine Mazindol Naphyrone Nefazodone Nefopam NS-2359 Perafensine PRC200 SEP-228431 SEP-228432 Tedatioxetine Tesofensine Tricyclic antidepressants (TCAs): Amitriptyline Butriptyline Cianopramine Clomipramine Desipramine Dosulepin Doxepin Imipramine Lofepramine Nortriptyline Pipofezine Protriptyline Trimipramine Others: A-80426 Amoxapine Antihistamines (e.g., brompheniramine , chlorphenamine , dimenhydrinate , diphenhydramine , mepyramine (pyrilamine) , pheniramine , tripelennamine ) Arylcyclohexylamines (e.g., esketamine , ketamine , phencyclidine ) CP-39332 Cyclobenzaprine Dextromethorphan Dextrorphan Efavirenz Etoperidone EXP-561 Fezolamine Litoxetine LY-393558 Loxapine Lubazodone Medifoxamine Mesembrine Mifepristone MIN-117 (WF-516) N-Me-5-HT Opioids (e.g., dextropropoxyphene , methadone , pethidine (meperidine) , levorphanol ) PIM-35 Pridefine Roxindole SB-649915 TGBA01AD Tofenacin Trazodone Tropanes (e.g., cocaine ) Vortioxetine Ziprasidone VMATs Amiodarone Amphetamines (e.g., amphetamine , methamphetamine , MDMA ) APP AZIK Bietaserpine Deserpidine Dihydrotetrabenazine Efavirenz GBR-12935 GZ-793A Ibogaine Ketanserin Lobeline Methoxytetrabenazine NBI-98854 Reserpine Rose bengal SD-809 Tetrabenazine Vanoxerine (GBR-12909) Releasing agents Aminoindanes: 5-IAI AMMI ETAI MDAI MDMAI MMAI TAI Aminotetralins: 6-CAT 8-OH-DPAT MDAT MDMAT Oxazolines: 4-Methylaminorex Aminorex Clominorex Fluminorex Phenethylamines: 2-Methyl-MDA 4-CAB 4-FA 4-FMA 4-HA 4-MTA 5-APDB 5-Methyl-MDA 6-APDB 6-Methyl-MDA AEMMA Amiflamine BDB BOH Brephedrone Butylone Chlorphentermine Cloforex Amfepramone Metamfepramone DCA Dexfenfluramine DFMDA DMA DMMA EBDB EDMA Ethylone Etolorex Fenfluramine Flephedrone Flucetorex IAP IMP Iofetamine Levofenfluramine Lophophine MBDB MDA MDEA MDHMA MDMA MDMPEA MDOH MDPEA Mephedrone Methedrone Methylone MMA MMDA MMDMA MMMA NAP Norfenfluramine 4-TFMA pBA pCA pIA PMA PMEA PMMA TAP Piperazines: 2C-B-BZP 3-MeOPP BZP DCPP MBZP mCPP MDBZP MeOPP Mepiprazole pCPP pFPP pTFMPP TFMPP Tryptamines: 4-Methyl-αET 4-Methyl-αMT 5-CT 5-MeO-αET 5-MeO-αMT 5-MT αET αMT DMT Tryptamine Others: Indeloxazine Tramadol Viqualine Enzyme inhibitors TPH AGN-2979 Fenclonine (PCPA) AAAD Benserazide Carbidopa Genistein Methyldopa MAO Non-selective: Benmoxin Caroxazone Echinopsidine Furazolidone Hydralazine Indantadol Iproclozide Iproniazid Isocarboxazid Isoniazid Linezolid Mebanazine Metfendrazine Nialamide Octamoxin Paraxazone Phenelzine Pheniprazine Phenoxypropazine Pivalylbenzhydrazine Procarbazine Safrazine Tranylcypromine MAO-A-selective: Amiflamine Bazinaprine Befloxatone Brofaromine Cimoxatone Clorgiline Eprobemide Esuprone Harmala alkaloids (e.g., harmine , harmaline , harman , norharman , tetrahydroharmine ) Methylene blue Metralindole Minaprine Moclobemide Pirlindole Sercloremine Tetrindole Toloxatone Tyrima Others Precursors L-Tryptophan → 5-HTP Cofactors Ferrous iron (Fe 2+ ) Magnesium (Mg 2+ ) Tetrahydrobiopterin Vitamin B 3 ( Niacin Nicotinamide → NADPH ) Vitamin B 6 ( Pyridoxine Pyridoxamine Pyridoxal → Pyridoxal phosphate ) Vitamin B 9 ( Folic Acid → Tetrahydrofolic acid ) Vitamin C ( Ascorbic acid ) Zinc (Zn 2+ ) Neurotoxins 3-CA 4-CAB 5,7-DHT α-Me-DA (3,4-DHA) αET αMT DCA MDA MDMA PBA PCA PIA Others Activity enhancers: BPAP PPAP See also: Adrenergics Dopaminergics Melatonergics Authority control LCCN : sh85148790 GND : 4190373-0 BNF : cb12144893f (data) NDL : 00575282
